Volume depletion

E4_VOLUME

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E86 Hospital discharge: ICD-9 — 2765 Hospital discharge: ICD-8 — 7880 Cause of death: ICD-10 — E86 Cause of death: ICD-9 — 2765 Cause of death: ICD-8 — 7880 2 out of 7 registries used, show all original rules.	4326
4. Check minimum number of events None	4326
5. Include endpoints None	4326
6. Filter based on genotype QC (FinnGen only)	4203

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E70-E90
Name in latin: Depletio voluminis liquoris

NAME	E4_VOLUME
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E86
HD_ICD_9	2765
HD_ICD_8	7880
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E86
COD_ICD_9	2765
COD_ICD_8	7880
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Volume depletion based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	44655	24590	19806
Only index persons	37185	20583	16602
Unadjusted period prevalence (%)
Whole population	0.63	0.70	0.55
Only index persons	0.70	0.76	0.63
Median age at first event (years)
Whole population	77.57	81.19	73.09
Only index persons	77.71	81.39	73.15

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4203	1895	2308
Unadjusted period prevalence (%)	0.88	0.67	1.06
Median age at first event (years)	73.46	73.14	73.72

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4326: Matched controls
43256

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

4.2

307.7

1318

4067

E87.6

ICD-10 Finland

Hypokalaemia

30.3

307.7

377

136

C03CA01

ATC

furosemide; systemic

3.5

307.7

2450

11861

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.1

307.7

1613

5451

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

44.3

307.7

482

122

E86

ICD-10 Finland

Volume depletion

41615.2

307.7

4238

E87.5

ICD-10 Finland

Hyperkalaemia

45.8

307.7

291

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.3

307.7

1047

2988

N17.9

ICD-10 Finland

Acute renal failure, unspecified

12.8

307.7

836

792

R53

ICD-10 Finland

Malaise and fatigue

3.9

307.7

1743

6383

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.8

296.9

1152

3769

AA1AD

NOMESCO Finland

CT of head and brain

3.2

289.1

1779

7743

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.6

288.2

1224

4243

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.9

278.8

684

1584

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

7.6

270.9

404

579

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

5.6

259.0

532

1053

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.9

250.7

864

2580

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.9

245.6

1854

8871

I50.9

ICD-10 Finland

Heart failure, unspecified

3.1

233.0

1301

5247

R11

ICD-10 Finland

Nausea and vomiting

4.2

225.9

681

1839

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

225.4

2450

13965

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.8

214.4

531

1229

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.4

212.2

904

3082

A10AB05

ATC

insulin aspart; parenteral

4.3

204.3

587

1524

A28

ICPC

Limited function/disability NOS

2.9

202.4

1287

5519

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.6

201.9

792

2556

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.0

194.1

1116

4518

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.6

193.7

743

2359

N19

ICD-10 Finland

Unspecified kidney failure

5.5

193.3

394

769

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.0

191.9

1064

4218

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

190.9

1621

8018

N05AH04

ATC

quetiapine; oral

3.1

190.3

1012

3917

JN3AD

NOMESCO Finland

Abdominal CT examination

3.6

188.0

731

2339

N17.8

ICD-10 Finland

Other acute renal failure

12.2

180.3

182

155

A10AE04

ATC

insulin glargine; parenteral

3.7

177.6

649

1989

N02AA05

ATC

oxycodone; systemic

2.7

177.0

1224

5432

C03DA01

ATC

spironolactone; oral

3.1

174.0

872

3247

SPAT1254

SPAT

Administration of medicine

2.8

171.1

1052

4383

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.7

170.5

1278

5891

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.4

170.3

1845

10104

C07AB07

ATC

bisoprolol; oral

2.4

167.6

2586

16503

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

166.3

1029

4295

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

162.9

820

3052

SPAT1262

SPAT

Handing over of treatment supplies

2.8

161.0

1037

4411

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.2

157.3

448

1148

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

14.9

156.5

140

I50.0

ICD-10 Finland

Congestive heart failure

3.2

156.1

723

2560

ZXD05

NOMESCO Finland

Urgent procedure

2.4

154.7

1584

8379

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.5

154.0

592

1867

N18.8

ICD-10 Finland

Other chronic renal failure

6.3

148.8

258

430

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.9

148.0

278

501

L28

ICPC

Limited function/disability (L)

2.6

144.7

1119

5181

N06AX11

ATC

mirtazapine; oral

2.3

142.0

1631

8996

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.4

140.7

1342

6827

I10

ICD-10 Finland

Essential (primary) hypertension

2.3

140.0

2926

20542

A04

ICPC

Weakness/tiredness general

2.7

139.6

898

3790

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

6.9

138.7

219

331

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.3

137.9

382

956

R55

ICD-10 Finland

Syncope and collapse

2.9

137.1

761

2970

R50.9

ICD-10 Finland

Fever, unspecified

2.7

136.5

883

3733

103

Kela drug reimbursment

Diabetes, insulin-treated

2.3

136.2

1484

7977

A02BC02

ATC

pantoprazole; systemic

2.3

130.8

3004

21622

SPAT1229

SPAT

Assessment of need for aid

3.2

130.4

594

2070

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.1

127.4

591

2080

I95.9

ICD-10 Finland

Hypotension, unspecified

7.4

127.3

188

264

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

126.0

660

2488

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.5

125.9

984

4543

I95.1

ICD-10 Finland

Orthostatic hypotension

4.1

124.3

362

939

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.5

124.2

323

769

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.6

123.3

864

3784

SPAT1216

SPAT

Assessment of functional ability

2.5

123.0

1015

4800

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.9

122.4

644

2432

J01MA02

ATC

ciprofloxacin; systemic

2.1

122.0

1970

12253

R06.0

ICD-10 Finland

Dyspnoea

2.2

120.5

1369

7418

G72.8

ICD-10 Finland

Other specified myopathies

6.9

120.2

189

284

TK800

NOMESCO Finland

Hemodialysis

7.0

120.2

187

278

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

119.9

1092

5389

N30.0

ICD-10 Finland

Acute cystitis

2.6

119.7

874

3899

T90

ICPC

Diabetes non-insulin dependent

2.3

119.1

1179

6028

A41.9

ICD-10 Finland

Sepsis, unspecified

4.3

117.9

326

813

R41.0

ICD-10 Finland

Disorientation, unspecified

4.4

116.3

311

756

SPAT1301

SPAT

No procedures

2.1

115.3

1612

9443

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.4

115.0

195

317

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.7

113.0

275

620

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

10.3

112.7

127

A46

ICD-10 Finland

Erysipelas

2.5

111.9

869

3979

A06AD11

ATC

lactulose; oral

2.3

111.4

1032

5109

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

6.2

111.1

195

328

N05AH03

ATC

olanzapine; systemic

3.8

109.7

362

1024

M04AA01

ATC

allopurinol; systemic

2.5

108.8

867

4012

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.5

108.3

411

1275

N05AX08

ATC

risperidone; systemic

2.8

107.7

620

2447

S97

ICPC

Chronic ulcer skin

3.3

107.1

439

1429

N02BE01

ATC

paracetamol; systemic, rectal

2.8

106.9

3799

31292

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.2

106.4

187

315

A10BH05

ATC

linagliptin; oral

3.6

106.0

370

1087

A11CC03

ATC

alfacalcidol; systemic

6.1

105.2

188

322

SPAT1263

SPAT

Sampling

2.0

104.9

1911

12223

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.9

104.6

552

2078

UJF32

NOMESCO Finland

Coloscopy

2.1

104.4

1306

7278

P15

ICPC

Chronic alcohol abuse

5.9

103.8

192

340

N05BA04

ATC

oxazepam; oral

2.1

102.9

1283

7135

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

101.5

1542

9218

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

101.1

1669

10275

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.1

100.6

1284

7192

F10.09

ICD-10 Finland

Alcohol intoxication UNS

6.9

100.5

157

234

E87.2

ICD-10 Finland

Acidosis

341.6

100.5

101

JN4AD

NOMESCO Finland

Body CT examination

2.8

100.2

579

2285

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

15.3

99.1

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.7

98.5

238

533

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

98.3

500

1842

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.8

97.9

552

2149

WX892

NOMESCO Finland

Monitored bed care

3.1

97.4

444

1537

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

10.8

97.0

105

SPAT1234

SPAT

Support of social functional capacity

3.2

96.4

423

1432

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.0

94.1

1420

8421

F10.24

ICD-10 Finland

Alcohol depence active use

8.8

93.9

119

139

R33

ICD-10 Finland

Retention of urine

2.7

92.9

579

2370

C08CA01

ATC

amlodipine; oral

1.9

92.6

1832

11907

N03AX16

ATC

[U] pregabalin

2.2

92.4

1057

5650

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.0

92.4

1343

7849

F05.9

ICD-10 Finland

Delirium, unspecified

4.8

92.3

213

459

N05CF01

ATC

zopiclone; oral

2.0

92.1

1611

10040

B01AC04

ATC

clopidogrel; oral

2.3

92.1

819

3950

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.9

91.3

467

1723

127

Kela drug reimbursment

Transplant complication

8.7

91.3

116

136

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.7

90.8

310

895

J01MA12

ATC

levofloxacin; systemic

2.2

90.6

986

5163

B03XA02

ATC

darbepoetin alfa; parenteral

5.5

90.2

177

331

Z94.0

ICD-10 Finland

Kidney transplant status

10.8

90.1

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.5

89.8

667

2967

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

20.0

89.7

Z2446

NOMESCO Finland

Social worker

3.1

88.8

395

1346

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

88.0

1089

5983

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.1

87.9

397

1365

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.4

87.5

686

3126

K59.09

ICD-10 Finland

Constipation, unspecified

3.0

87.4

410

1440

A10BA02

ATC

metformin; oral

2.0

87.4

1377

8249

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

10.4

87.2

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.7

87.2

520

2079

N03AG01

ATC

valproic acid; systemic, rectal

3.4

86.8

334

1042

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.1

86.4

394

1362

L04AA06

ATC

mycophenolic acid; systemic

7.3

86.0

127

178

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.4

85.9

723

3397

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

85.7

874

4450

Z49.1

ICD-10 Finland

Extracorporeal dialysis

7.5

85.2

123

168

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.7

85.0

203

450

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.3

84.6

175

343

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

6.9

84.3

131

194

M10.9

ICD-10 Finland

Gout, unspecified

2.9

84.0

432

1596

F10.25

ICD-10 Finland

Alcohol dependence continuous use

7.1

83.9

128

186

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.4

83.0

122

170

N02AX02

ATC

tramadol; systemic, rectal

1.9

82.5

1895

12785

C09AA05

ATC

ramipril; oral

2.0

82.2

1299

7759

J01DB01

ATC

cefalexin; oral

2.1

81.9

3390

27556

V03AE01

ATC

polystyrene sulfonate; oral

7.0

81.7

125

182

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.6

81.7

278

800

L04AD02

ATC

tacrolimus; systemic

11.9

81.7

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.5

81.2

600

2655

N05AA02

ATC

levomepromazine; systemic

3.8

80.6

262

731

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

80.1

1392

8569

A10AE05

ATC

insulin detemir; parenteral

3.4

80.1

312

980

Z93.2

ICD-10 Finland

Ileostomy status

16.6

79.7

TKC20

NOMESCO Finland

Catheterisation of bladder

2.8

79.7

452

1758

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

13.7

79.3

C10AA01

ATC

simvastatin; oral

1.8

79.1

1941

13311

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

12.0

79.0

R60.0

ICD-10 Finland

Localized oedema

2.3

78.6

668

3143

S06.0

ICD-10 Finland

Concussion

2.5

78.5

566

2475

A12AA04

ATC

calcium carbonate; oral

6.8

78.1

124

188

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

11.6

77.6

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.7

77.5

255

717

R42

ICD-10 Finland

Dizziness and giddiness

2.0

77.5

1116

6435

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

4.2

77.2

209

511

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

12.7

76.9

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

8.9

76.9

110

N30.9

ICD-10 Finland

Cystitis, unspecified

2.9

76.3

386

1411

A10AC01

ATC

insulin (human); parenteral

2.7

75.9

465

1879

SPAT1255

SPAT

Intravenous administration of medicine

2.8

74.8

400

1506

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

258.1

74.6

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.0

74.4

360

1284

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.4

74.0

191

450

JFF10

NOMESCO Finland

Loop enterostomy

11.0

73.9

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.6

73.4

176

391

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.7

72.9

237

661

H02AB06

ATC

prednisolone; systemic

1.8

72.6

2045

14492

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.3

72.4

288

915

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.0

72.2

1029

5891

N06AB04

ATC

citalopram; systemic

2.0

72.0

947

5271

ZX120

NOMESCO Finland

Intravenous

2.5

71.9

482

2032

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

71.9

508

2196

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

18.6

71.7

N07BB01

ATC

disulfiram; oral

4.1

71.4

204

519

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.1

71.3

312

1050

E83.50

ICD-10 Finland

Hypercalcemia

12.7

70.9

Z51.5

ICD-10 Finland

Palliative care

2.5

70.4

502

2178

H02AB09

ATC

hydrocortisone; systemic

5.2

70.2

147

291

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.7

70.2

417

1657

JAH00

NOMESCO Finland

Laparotomy

3.9

70.0

211

558

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.7

70.0

230

646

A07AA09

ATC

vancomycin; oral

6.2

69.7

121

201

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.4

69.7

269

839

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.6

68.8

131

238

A10BH01

ATC

sitagliptin; oral

2.5

68.7

490

2125

Z02.7

ICD-10 Finland

Issue of medical certificate

2.8

68.7

377

1438

N18.0

ICD-10 Finland

End-stage renal disease

6.9

68.6

106

156

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

68.6

1282

8004

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.8

68.5

127

225

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.6

68.5

111

172

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

30.3

68.2

W19

ICD-10 Finland

Unspecified fall

2.4

67.2

541

2476

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.5

67.2

242

722

S01.0

ICD-10 Finland

Open wound of scalp

2.5

67.1

459

1952

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.5

66.9

132

248

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.1

66.7

716

3686

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

66.7

1276

8011

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

9.7

66.6

B01AB05

ATC

enoxaparin; parenteral

1.8

66.6

1365

8751

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

66.5

661

3302

N06AX16

ATC

venlafaxine; oral

2.4

66.5

520

2350

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

7.2

66.5

140

Z3231

NOMESCO Finland

Registered nurse

1.9

66.3

1229

7638

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.7

66.3

125

225

N05CD07

ATC

temazepam; oral

2.1

66.2

726

3767

SPAT1260

SPAT

Consultation of another employee

2.0

66.1

815

4418

AN1

Coronary angiography

2.3

65.0

567

2684

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

64.9

564

2666

R4110

NOMESCO Finland

Physiotherapy

1.9

64.8

1139

6954

B01AA03

ATC

warfarin; systemic

1.8

64.7

1190

7367

A01

ICPC

Pain general/multiple sites

2.5

64.7

446

1902

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

64.7

395

1589

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

64.4

814

4447

T89

ICPC

Diabetes insulin dependent

4.0

64.4

191

499

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

64.1

857

4776

K92.1

ICD-10 Finland

Melaena

2.8

63.8

352

1345

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.8

63.6

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.5

63.4

421

1764

JFF13

NOMESCO Finland

Terminal enterostomy

18.7

63.1

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

14.4

63.0

N05AH02

ATC

clozapine; systemic

6.5

62.5

102

159

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.7

62.1

147

323

137

Kela drug reimbursment

Uraemia requiring dialysis

8.8

62.1

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

10.1

62.0

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

61.8

376

1509

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

13.7

61.3

C10AA05

ATC

atorvastatin; oral

1.7

61.3

1647

11355

Z49.2

ICD-10 Finland

Other dialysis

9.7

61.0

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.1

60.9

170

425

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

60.5

1060

6443

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

13.8

60.5

N05AX12

ATC

aripiprazole; systemic

4.2

60.4

162

393

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

8.8

60.3

B01AF02

ATC

apixaban; oral

2.1

59.9

672

3508

C09AA02

ATC

enalapril; systemic

1.9

59.8

1031

6231

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

59.5

1166

7328

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

59.4

717

3842

B05DB

ATC

Hypertonic solutions

10.6

58.6

P16

ICPC

Acute alcohol abuse

6.3

58.3

161

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

11.0

58.2

I50

ICD-10 Finland

Heart failure

3.1

57.8

253

850

B03BA03

ATC

hydroxocobalamin; parenteral

2.5

57.8

385

1613

205

Kela drug reimbursment

Chronic hypertension

1.7

57.6

1448

9762

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

57.5

933

5524

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.1

57.1

160

401

N05BA01

ATC

diazepam; systemic, rectal

2.1

57.0

627

3243

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.6

56.7

191

545

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

8.9

56.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

56.0

713

3888

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.4

55.9

148

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

54.8

1503

10341

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

54.8

853

4974

SPAT1125

SPAT

Stoma care and guidance

4.3

54.7

143

340

UKC02

NOMESCO Finland

Cystoscopy

1.9

54.6

852

4972

SPAT1167

SPAT

Insertion of urinary catheter

3.1

54.6

236

787

B05DA

ATC

Isotonic solutions

9.4

54.5

P29

ICPC

Psychological sympt/compl other

3.0

54.5

257

901

207

Kela drug reimbursment

Chronic arrhythmias

1.9

54.4

862

5055

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.2

54.0

518

2539

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.4

53.8

420

1889

E66.00

ICD-10 Finland

Metabolic syndrome

3.3

53.8

213

674

C02AC05

ATC

moxonidine; oral

3.0

53.5

244

839

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

53.3

322

1285

L04AX01

ATC

azathioprine; systemic

3.3

53.2

212

673

SPAT1252

SPAT

Overall medication plan or its review

2.4

53.0

394

1734

N05BA06

ATC

lorazepam; systemic, sublingual

2.6

52.8

314

1244

ZY000

NOMESCO Finland

Hospital inpatient

6.7

52.6

128

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.4

52.6

133

308

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

52.5

286

1083

K56.7

ICD-10 Finland

Ileus, unspecified

4.4

52.5

135

317

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.6

52.4

319

1278

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.5

52.1

102

190

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

52.1

802

4653

WX730

NOMESCO Finland

Conventional respirator

4.9

51.9

116

243

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.8

51.8

273

1016

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

22.5

51.8

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

51.5

465

2222

TJF80

NOMESCO Finland

Ostomy education

6.5

51.5

131

Z72.1

ICD-10 Finland

Alcohol use

6.6

51.4

128

N06AX21

ATC

duloxetine; oral

2.3

51.3

446

2099

J01EA01

ATC

trimethoprim; systemic

1.7

51.0

1161

7564

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

7.5

50.8

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.9

50.8

153

404

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

5.5

50.7

184

N05AN01

ATC

lithium; oral

4.5

50.7

124

280

N03AX09

ATC

lamotrigine; oral

3.5

50.6

179

527

B01AB10

ATC

tinzaparin; parenteral

2.3

50.5

432

2018

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

8.9

50.5

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.7

50.5

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

12.3

50.4

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

8.6

50.3

I20.09

ICD-10 Finland

Unstable angina

2.6

50.3

307

1231

SPAT1139

SPAT

Nutrition survey

3.2

50.3

206

665

K77

ICPC

Heart failure

3.6

50.2

173

501

E83.51

ICD-10 Finland

Hypocalcemia

81.1

50.0

N05AF03

ATC

chlorprothixene; systemic

4.2

49.7

134

326

I95.8

ICD-10 Finland

Other hypotension

10.7

49.7

N06AB10

ATC

escitalopram; oral

1.9

49.6

705

3978

A41.8

ICD-10 Finland

Other specified sepsis

4.1

49.6

138

344

C10AC01

ATC

colestyramine; oral

3.8

49.5

152

407

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.1

49.4

532

2723

JN4BD

NOMESCO Finland

Extensive body CT

2.1

49.2

514

2599

J01FF01

ATC

clindamycin; systemic

1.7

49.1

1078

6941

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.5

49.0

315

1295

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

48.9

217

734

R4190

NOMESCO Finland

Nutritional therapy

3.4

48.9

178

534

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.0

48.6

140

358

N03AX12

ATC

[U] gabapentin; oral

2.0

48.6

652

3607

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.8

48.5

156

2765A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Volume depletion

+∞

48.0

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

47.9

751

4371

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.4

47.8

177

537

E0000UV, ,

ATC

1.6

47.8

1628

11737

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.8

47.7

257

967

C01DA14

ATC

isosorbide mononitrate; oral

1.8

47.4

889

5464

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.7

47.4

111

242

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

47.1

383

1750

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.9

47.1

223

783

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.8

47.0

106

224

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.4

46.9

343

1496

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.5

46.9

167

494

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.8

46.9

148

404

V03AE02

ATC

sevelamer; oral

11.0

46.8

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

46.7

1703

12461

I50.1

ICD-10 Finland

Left ventricular failure

2.4

46.4

325

1390

C07AB02

ATC

metoprolol; systemic

1.7

46.2

1040

6727

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

46.1

1537

10996

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

6.4

46.0

120

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.8

46.0

143

386

H04AA01

ATC

glucagon; nasal, parenteral

4.9

45.6

102

214

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

45.5

1894

14269

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

45.5

1662

12144

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

45.4

391

1830

K59.1

ICD-10 Finland

Functional diarrhoea

2.7

45.2

261

1017

A04AA01

ATC

ondansetron; systemic, rectal

2.3

45.2

350

1565

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.4

45.2

345

1533

H3603, E103,

ICD-10 Finland

10.1

45.1

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

44.9

1085

7144

K08.3

ICD-10 Finland

Retained dental root

2.3

44.9

349

1564

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.3

44.6

343

1530

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.2

44.3

394

1867

A10BB12

ATC

glimepiride; oral

2.2

44.3

414

2002

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

11.0

44.2

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

9.6

44.2

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.6

44.1

106

236

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

7.0

44.0

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

43.8

231

859

H36.00

ICD-10 Finland

Diabetic background retinopathy

5.5

43.7

154

J01MA14

ATC

moxifloxacin; systemic

2.2

43.6

412

2000

P01AB01

ATC

metronidazole; oral, rectal

1.6

43.6

1418

10053

P20

ICPC

Memory disturbance

1.8

43.5

762

4577

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.5

43.5

155

459

JFH10

NOMESCO Finland

Total colectomy and ileostomy

14.6

43.3

A29

ICPC

General symptom/complaint other

1.9

43.2

576

3172

WW500

NOMESCO Finland

Blood transfusion

2.8

43.0

219

800

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

42.8

577

3188

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

42.8

931

5948

A10AE06

ATC

insulin degludec; parenteral

3.6

42.8

146

420

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

10.8

42.6

NF1AA

NOMESCO Finland

Hip X-ray examination

2.1

42.4

458

2340

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.5

42.2

282

1179

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.2

42.1

379

1804

SPAT1251

SPAT

Organisation of medication

2.7

42.1

228

860

SPAT1172

SPAT

Guidance concerning hydration

3.2

42.1

175

570

I95.2

ICD-10 Finland

Hypotension due to drugs

6.7

42.0

102

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.5

42.0

149

440

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

41.9

344

1576

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.8

41.8

198

K92.0

ICD-10 Finland

Haematemesis

3.2

41.8

166

526

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.9

41.6

124

325

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

6.8

41.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.1

41.5

179

596

A10AB01

ATC

insulin (human); parenteral

3.2

41.3

172

561

ZXE00

NOMESCO Finland

One hour or less

1.6

41.2

1509

10966

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.5

41.0

145

427

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.1

41.0

398

1952

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

41.0

752

4572

TK820

NOMESCO Finland

Peritoneal dialysis

11.1

40.6

Z49.0

ICD-10 Finland

Preparatory care for dialysis

6.3

40.6

109

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.8

40.5

737

4468

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.6

40.4

138

397

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

40.3

1314

9283

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

40.3

574

3226

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

7.1

40.2

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.4

40.1

291

1263

SPAT1240

SPAT

Therapeutic discussion

2.2

40.1

343

1598

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

40.1

467

2450

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.4

40.1

280

1195

TK810

NOMESCO Finland

Hemofiltration

9.3

40.1

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.3

40.0

154

479

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.6

39.9

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.9

39.8

194

692

Z3226

NOMESCO Finland

Physiotherapist

1.8

39.7

737

4491

F03

ICD-10 Finland

Unspecified dementia

2.2

39.7

339

1579

78800

ICD-8 Finland

Other general symptoms, Electrolyte disorders

+∞

39.6

SPAT1265

SPAT

Breathalyser

7.3

39.0

Z00.8

ICD-10 Finland

Other general examinations

2.3

38.6

312

1419

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.8

38.6

118

315

C03AA03

ATC

hydrochlorothiazide; oral

2.0

38.3

454

2396

K56.0

ICD-10 Finland

Paralytic ileus

5.4

38.2

144

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

4.1

38.0

107

269

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.3

37.9

231

WX882

NOMESCO Finland

High dependency care

3.2

37.9

157

510

A02BC01

ATC

omeprazole; systemic

1.6

37.9

1173

8163

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

5.3

37.9

145

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.4

37.8

285

1258

K51.5

ICD-10 Finland

Left sided colitis

3.6

37.6

128

368

A10AB04

ATC

insulin lispro; parenteral

3.5

37.5

129

373

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.8

37.5

198

737

JFB00

NOMESCO Finland

Partial resection of small intestine

4.1

37.4

103

255

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

4.5

37.3

205

C08CA13

ATC

lercanidipine; oral

1.8

37.3

619

3645

A07EC02

ATC

mesalazine; oral, rectal

2.6

37.3

231

932

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

37.2

631

3740

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.2

37.1

325

1528

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

8.0

37.1

M54.5

ICD-10 Finland

Low back pain

1.6

37.1

1225

8649

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.6

37.0

214

834

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

6.1

37.0

106

H3600, E103,

ICD-10 Finland

7.8

37.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

37.0

1447

10613

U04

ICPC

Incontinence urine

2.3

36.9

289

1297

WX872

NOMESCO Finland

Intensive care

2.6

36.9

224

895

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.8

36.7

611

3600

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.4

36.6

255

1087

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

9.9

36.5

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

36.4

474

2582

ZY010

NOMESCO Finland

Hospital outpatient

2.8

36.3

190

704

SPAT1211

SPAT

Application of soft bandage

2.0

36.3

403

2076

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.7

36.1

119

N02BF02

ATC

pregabalin; oral

2.5

35.9

225

912

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

12.6

35.8

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

35.7

254

1092

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.6

35.7

214

849

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

35.7

182

665

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.5

35.5

126

372

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.2

35.4

235

ZXA05

NOMESCO Finland

Left side

1.6

35.3

1046

7183

H02AA02

ATC

fludrocortisone; oral

5.1

35.3

147

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.8

35.2

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.6

35.1

122

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

34.8

279

1264

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.4

34.8

200

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.2

34.7

141

453

R51.80

ICD-10 Finland

Headache

1.9

34.7

501

2821

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.0

34.7

153

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

34.6

481

2674

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.0

34.6

103

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

34.5

830

5409

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

34.4

335

1642

SPAT1053

SPAT

Memory test

1.7

34.4

776

4974

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

6.2

34.4

P99

ICPC

Psychological disorders other

3.6

34.4

114

322

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.4

34.3

198

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

34.3

215

872

R03BB04

ATC

tiotropium bromide; inhalant

1.9

34.3

508

2884

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.9

34.2

155

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

34.1

387

2007

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.4

34.1

195

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.1

34.1

144

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.4

34.0

249

1085

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

6.2

33.9

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.5

33.9

219

901

I25.2

ICD-10 Finland

Old myocardial infarction

2.1

33.9

363

1844

Y94.0

ICD-10 Finland

Accident at home

3.5

33.9

120

354

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

33.8

135

429

S18

ICPC

Laceration/cut

1.5

33.8

1752

13562

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.1

33.8

355

1790

J01DA01

ATC

[U] cefalexin

1.5

33.7

2398

19764

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

33.6

320

1554

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.1

33.6

147

493

H36.01

ICD-10 Finland

Diabetic maculopathy

4.6

33.6

173

WZC30

NOMESCO Finland

Teaching

1.8

33.5

572

3390

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.7

33.4

110

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.7

33.4

180

677

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.0

33.3

100

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

33.3

247

1082

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.6

33.2

204

819

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.6

33.2

202

808

K59.0

ICD-10 Finland

Constipation

2.2

33.0

287

1344

J01CA08

ATC

pivmecillinam; oral

1.5

33.0

1441

10759

RD210, ,

NOMESCO Finland

4.0

32.9

239

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

32.7

325

1604

SPAT1101

SPAT

Orthostatic test

2.3

32.7

272

1252

Z43.5

ICD-10 Finland

Attention to cystostomy

5.7

32.7

109

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.0

32.5

144

487

R4180

NOMESCO Finland

Podiatric therapy

5.1

32.4

135

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.5

32.4

174

N06AB06

ATC

sertraline; oral

2.0

32.4

383

2015

196

Kela drug reimbursment

Paricalcitol and cinacalcet

9.6

32.4

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.5

32.3

210

866

H03AA01

ATC

levothyroxine sodium; systemic

1.6

32.3

830

5492

K07

ICPC

Swollen ankles/oedema

2.3

32.3

244

1078

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.5

32.2

114

336

H05BX01

ATC

cinacalcet; oral

7.1

32.2

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.6

32.0

192

762

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.4

32.0

238

1044

EBA30

NOMESCO Finland

Extraction of root of tooth

2.3

31.9

255

1153

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

31.9

179

687

A10BK01

ATC

dapagliflozin; oral

2.3

31.8

263

1207

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

31.8

254

1149

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

166.2

31.7

R02

ICPC

Shortness of breath/dyspnoea

1.8

31.7

521

3049

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.0

31.6

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

31.6

1064

7497

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

10.4

31.6

R5110, ,

SPAT

2.2

31.5

280

1323

SPAT1097

SPAT

Recording of ECG

1.7

31.5

611

3751

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

9.6

31.5

SPAT1307

SPAT

Psychosocial counselling and guidance

2.5

31.3

199

813

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

31.2

312

1543

J01CA04

ATC

amoxicillin; systemic

1.5

31.2

3067

26739

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.8

31.1

158

576

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

8.7

31.0

A07EA06

ATC

budesonide; oral, local oral

2.9

31.0

150

533

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

11.5

30.9

F34.1

ICD-10 Finland

Dysthymia

3.1

30.9

132

437

S70.0

ICD-10 Finland

Contusion of hip

2.4

30.9

216

922

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.0

30.8

135

454

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.6

30.7

100

279

I20.00

ICD-10 Finland

Unstable angina

2.8

30.7

162

603

N06AA09

ATC

amitriptyline; systemic

1.9

30.7

403

2197

WX610

NOMESCO Finland

Patient controlled analgesia

6.6

30.6

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

30.5

946

6534

E000001, ,

ATC

1.6

30.5

774

5097

SPAT1312

SPAT

General health counselling

1.5

30.5

1172

8490

A12BA01

ATC

potassium chloride; oral

2.1

30.4

295

1442

E66.8

ICD-10 Finland

Other obesity

2.9

30.4

149

533

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

8.2

30.3

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

30.3

2455

20548

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.4

30.3

213

911

M79.6

ICD-10 Finland

Pain in limb

1.5

30.3

1429

10793

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

30.2

316

1591

N06DX01

ATC

memantine; oral

1.8

30.1

496

2902

SPAT1304

SPAT

Counselling and guidance related to ageing

1.9

30.1

412

2277

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.4

30.0

206

872

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.0

30.0

211

K65.0

ICD-10 Finland

Acute peritonitis

4.1

29.9

207

P76

ICPC

Depressive disorder

2.5

29.9

196

812

K90

ICPC

Stroke/cerebrovascular accident

2.8

29.8

150

544

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.9

29.8

144

511

SPAT1104

SPAT

Monitoring of emergency patient

2.1

29.8

297

1468

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

6.1

29.7

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.4

29.7

170

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

29.6

313

1580

G04CA02

ATC

tamsulosin; oral

1.5

29.6

1160

8427

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

8.2

29.5

R31

ICD-10 Finland

Unspecified haematuria

1.8

29.4

492

2891

EBA00

NOMESCO Finland

Extraction of tooth

1.5

29.4

1241

9151

Z93

ICD-10 Finland

Artificial opening status

9.8

29.4

RS220, ,

NOMESCO Finland

4.2

29.4

188

N05AB03

ATC

perphenazine; systemic, rectal

2.8

29.3

149

544

SPAT1310

SPAT

Counselling related to known health issue

1.5

29.2

1192

8729

A99

ICPC

Disease/condition unspecnature/site

1.9

29.2

375

2028

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.4

29.2

215

939

WX002

NOMESCO Finland

Sedation and analgesia

1.6

29.1

739

4862

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

5.5

29.1

103

ZXA00

NOMESCO Finland

Right side

1.5

29.1

1088

7822

N03AX14

ATC

levetiracetam; systemic

3.1

29.1

123

405

M10.0

ICD-10 Finland

Idiopathic gout

2.6

29.1

168

655

L17

ICPC

Foot/toe symptom/complaint

1.5

29.1

1015

7190

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.0

29.0

343

1804

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.0

28.9

132

454

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

28.9

1628

12695

A10BK03

ATC

empagliflozin; oral

2.0

28.9

340

1785

H3601, E103,

ICD-10 Finland

7.3

28.8

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.2

28.7

266

1277

A10BJ02

ATC

liraglutide; parenteral

3.5

28.7

287

R13

ICD-10 Finland

Dysphagia

2.1

28.6

301

1518

V03AE03

ATC

lanthanum carbonate; oral

11.2

28.4

C01AA05

ATC

digoxin; systemic

1.7

28.3

539

3286

ZXD35

NOMESCO Finland

Usual procedure

2.7

28.3

152

571

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

10.1

28.3

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

4.8

28.2

136

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.0

28.2

203

F31

ICD-10 Finland

Bipolar affective disorder

5.5

28.1

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

28.1

588

3678

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.9

28.1

131

456

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

28.1

381

2098

U05

ICPC

Urination problems other

2.2

28.0

244

1143

L04AD01

ATC

ciclosporin; systemic

4.0

28.0

204

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.4

28.0

101

302

R04.0

ICD-10 Finland

Epistaxis

1.9

27.9

358

1935

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

27.9

213

945

H02AB04

ATC

methylprednisolone; systemic

1.7

27.9

562

3481

K50.8

ICD-10 Finland

Other Crohn disease

4.3

27.8

166

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.5

27.8

182

754

WX402

NOMESCO Finland

General anaesthesia

1.6

27.8

655

4227

M10

ICD-10 Finland

Gout

2.4

27.8

204

890

N05AD01

ATC

haloperidol; systemic

2.5

27.6

185

774

A07AA11

ATC

rifaximin; oral

11.2

27.6

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

27.4

277

1376

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

4.1

27.2

186

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

27.1

183

768

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.9

27.1

131

465

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.6

27.1

161

636

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.9

27.0

131

466

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

27.0

729

4859

WVA20

NOMESCO Finland

Medicine administration

3.1

27.0

112

365

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.8

26.8

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

26.7

156

611

321

Kela drug reimbursment

Paricalcitol and cinacalcet

6.7

26.7

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

7.5

26.7

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

3.2

26.7

104

326

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.0

26.7

119

404

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

26.7

410

2346

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

5.8

26.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

26.6

170

696

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.8

26.6

139

515

D11

ICPC

Diarrhoea

1.9

26.4

373

2078

R10.0

ICD-10 Finland

Acute abdomen

2.9

26.4

129

461

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

4.0

26.4

186

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

7.9

26.4

J96.0

ICD-10 Finland

Acute respiratory failure

3.7

26.3

236

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

26.3

274

1375

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.2

26.3

232

1093

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.2

26.2

103

325

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

26.0

339

1840

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.5

26.0

160

643

R03AC02

ATC

salbutamol; inhalant

1.4

25.9

1922

15657

A10AA01, ,

ATC

3.2

25.9

101

317

A10AD05

ATC

insulin aspart; parenteral

2.9

25.9

123

433

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.9

25.8

339

1845

S00.0

ICD-10 Finland

Superficial injury of scalp

2.9

25.8

121

423

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.2

25.8

Z29.0

ICD-10 Finland

Isolation

8.5

25.7

XKD00

NOMESCO Finland

Uroflowmetry

1.6

25.7

744

5035

160

Kela drug reimbursment

exenatide

3.9

25.7

194

D94

ICPC

Chronic enteritis/ulcerative colitis

5.9

25.7

R07.3

ICD-10 Finland

Other chest pain

1.8

25.6

380

2152

S72.0

ICD-10 Finland

Fracture of neck of femur

2.1

25.5

267

1343

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.1

25.5

169

P72

ICPC

Schizophrenia

3.8

25.5

209

K50.0

ICD-10 Finland

Crohn disease of small intestine

4.2

25.4

165

N18

ICD-10 Finland

Chronic kidney disease

4.0

25.4

178

D10

ICPC

Vomiting

2.4

25.4

174

736

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.2

25.4

228

1082

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.5

25.4

247

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.3

25.3

291

Angiography of the heart and coronary arteries

1.9

25.3

313

1669

Z2221

NOMESCO Finland

Medical doctor

1.5

25.2

970

6982

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.5

25.1

159

648

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

7.7

25.0

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.8

25.0

N06AX26

ATC

vortioxetine; oral

2.2

25.0

224

1062

N06AB03

ATC

fluoxetine; oral

1.8

25.0

419

2461

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

24.9

243

1190

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.8

24.9

129

476

N06AA12

ATC

doxepin; systemic

2.2

24.9

224

1064

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.8

24.9

208

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.0

24.8

113

389

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.7

24.7

130

483

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2038

9167

3.31

320.01

3.3

2.0

277.64

228.94

u/l

1.15

1939

8479

(3026008) Bacteria identified in Urine by Culture

2212

10482

3.27

317.29

5.1

3.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1367

4862

3.65

312.42

3.8

2.3

10.80

12.58

umol/l

9.66

1256

4470

(3022217) INR in Platelet poor plasma by Coagulation assay

2837

15659

3.36

311.62

24.9

17.7

1.29

1.37

inr

4.87

927

4400

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1247

4185

3.78

310.97

3.9

2.3

21.16

22.30

1.42

1082

3528

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1297

4481

3.71

309.47

3.8

2.2

2.15

2.28

g/l

10.28

1187

4090

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2080

9633

3.23

307.97

4.4

2.4

57.87

60.07

u/l

0.68

1970

8820

(3023368) Bacteria identified in Blood by Culture

2377

9331

4.43

307.65

7.0

4.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1434

3791

5.16

307.65

9.5

5.0

1.07

1.04

mmol/l

2.81

1343

3452

(3020779) Urea [Moles/volume] in Serum or Plasma

1158

2683

5.53

307.65

10.7

6.0

12.81

10.36

mmol/l

16.77

1098

2523

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

588

937

7.10

307.65

1.6

1.2

—

(3002032) Base excess in Venous blood by calculation

1112

3001

4.64

307.65

6.4

3.5

1.82

2.00

mmol/l

0.61

922

2460

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

982

2263

5.32

307.65

2.3

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2695

13786

3.53

307.65

8.8

4.4

32.05

34.91

g/l

98.66

2528

12608

(3012544) pH of Venous blood

1145

3071

4.71

307.65

6.3

3.6

7.39

7.38

0.07

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1529

4663

4.52

307.65

5.8

3.1

0.78

0.82

mmol/l

20.64

1437

4294

(3014111) Lactate [Moles/volume] in Serum or Plasma

1007

2695

4.57

307.65

8.3

5.6

1.58

1.43

mmol/l

2.85

969

2603

(3024354) Oxygen [Partial pressure] in Venous blood

951

2543

4.51

307.65

5.7

3.1

4.49

4.48

kpa

0.09

902

2444

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1488

5450

3.64

307.65

2.4

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1128

3010

4.72

307.65

6.4

3.5

5.85

5.84

kpa

0.05

1078

2902

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1137

3625

3.90

305.14

9.1

6.0

5.01

5.10

kpa

1.86

1079

3422

(3003396) Base excess in Arterial blood by calculation

1135

3618

3.90

304.63

9.1

6.0

1.15

1.17

mmol/l

0.03

915

2798

(3027801) Oxygen [Partial pressure] in Arterial blood

1136

3624

3.89

304.54

9.0

6.0

11.31

12.09

kpa

5.99

1076

3418

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2860

16117

3.29

297.90

9.9

5.8

11.78

12.55

umol/l

1.79

2739

15186

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2851

16042

3.28

297.64

14.1

5.8

1.20

1.21

mmol/l

23.26

2405

13411

(3000991) Gas panel - Venous blood

926

2593

4.27

297.31

10.5

6.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1901

8492

3.21

297.02

3.1

2.2

3.43

3.11

mg/l

5.06

1664

7160

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2654

14512

3.14

287.60

13.4

5.2

1.20

1.21

mmol/l

17.58

2493

12995

(3016502) Oxygen saturation in Arterial blood

1028

3194

3.91

284.56

9.5

6.3

95.26

95.25

0.01

993

3065

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2380

12511

3.01

271.79

7.3

3.6

45.07

98.67

ng/l

0.90

2051

9250

(3026782) Osmolality of Urine

1562

6546

3.17

267.07

4.7

2.8

498.90

557.55

mosm/kgh2o

25.03

1420

5568

(3013826) Glucose [Moles/volume] in Serum or Plasma

3055

18571

3.19

265.43

10.6

4.2

7.30

6.76

mmol/l

23.49

2954

17301

(3023183) Ammonium ion [Moles/volume] in Plasma

389

558

7.56

260.49

2.9

2.6

34.40

35.43

umol/l

0.16

357

490

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

643

1498

4.87

259.35

6.1

4.1

23.57

24.08

mmol/l

2.68

619

1452

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1064

3669

3.52

248.77

2.3

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1063

3667

3.52

248.34

2.3

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

781

2221

4.07

242.27

2.5

2.2

385.87

367.15

nmol/l

1.21

717

2000

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

758

2124

4.11

239.85

6.5

3.6

5.02

5.18

kpa

4.50

728

1982

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

902

2870

3.71

237.64

2.9

2.2

0.19

0.20

g/l

1.88

815

2658

(3002582) Erythrocytes [#/volume] in Urine

1962

9804

2.83

237.53

5.5

3.1

61.28

91.78

e6/l

1.26

1702

7540

(3009343) pH of Capillary blood

748

2091

4.12

237.32

6.5

3.6

7.41

7.42

1.29

170

230

(3003181) Sodium [Moles/volume] in Urine

283

313

9.60

234.31

2.2

1.2

61.36

68.42

mmol/l

1.30

224

228

(3002173) Hemoglobin [Mass/volume] in Arterial blood

899

2886

3.67

233.38

10.2

6.6

116.54

120.78

g/l

6.67

885

2804

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

708

1929

4.19

232.39

1.9

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

728

2036

4.10

230.46

6.5

3.6

1.75

1.92

mmol/l

0.42

530

1477

(3019309) Folate [Moles/volume] in Red Blood Cells

1553

7052

2.88

222.68

2.3

1.8

1349.84

1165.90

nmol/l

8.89

1215

5223

(3027945) Reticulocytes/100 erythrocytes in Blood

1075

3981

3.26

221.38

2.8

2.6

1.92

1.73

7.60

936

3465

(1616796) Gas panel - Central venous blood

392

675

6.29

220.04

5.9

3.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1976

10222

2.72

219.06

4.6

2.9

2747.38

1725.87

ng/l

11.13

1760

8728

(3000850) Epithelial cells [#/volume] in Urine

1530

6965

2.85

217.44

4.2

2.5

6.37

5.14

e6/l

3.42

1430

6164

(3019060) Gas panel - Arterial blood

740

2183

3.88

216.53

6.7

4.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

426

807

5.75

216.45

4.9

2.9

23.86

25.06

mmol/l

4.60

417

783

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

662

1869

4.00

205.61

9.4

6.6

24.25

24.96

mmol/l

3.73

655

1852

(3018418) pH of Serum or Plasma

1814

9220

2.67

205.13

8.1

3.5

7.40

0.34

508

1773

(3018095) Leukocytes [#/volume] in Urine

2073

11243

2.62

205.09

6.6

3.5

211.48

115.28

e6/l

2.11

1750

8091

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

542

1329

4.52

203.20

2.3

1.8

2.63

2.47

ug/l

0.09

497

1127

(3030467) Casts [#/volume] in Urine by Automated count

1767

8977

2.64

198.55

5.1

3.1

0.98

0.48

e6/l

5.55

1524

6895

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2189

12376

2.56

195.76

4.3

2.7

196.32

144.94

ug/l

8.56

1999

11149

(3004119) Hemoglobin [Mass/volume] in Venous blood

652

1884

3.90

195.47

5.5

3.0

122.74

127.53

g/l

5.36

634

1837

(3031040) Bacteria [#/volume] in Urine by Automated count

3162

21338

2.79

194.43

8.5

4.6

2057.24

3105.68

e6/l

0.52

312

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

980

3720

3.11

190.70

3.7

4.1

238.81

246.22

u/l

1.13

913

3490

(40760892) CBC W Ordered Manual Differential panel - Blood

2366

13990

2.53

190.46

9.2

6.1

—

(3023520) Reticulocytes [#/volume] in Blood

843

2968

3.29

185.94

3.0

2.7

70.41

67.57

e9/l

1.37

681

2259

(3008152) Bicarbonate [Moles/volume] in Arterial blood

663

2026

3.68

182.52

11.1

6.3

24.06

24.60

mmol/l

2.04

643

1929

(3006315) Basophils [#/volume] in Blood

2462

15028

2.48

181.91

8.0

5.4

0.04

e9/l

0.15

2210

12850

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

455

1061

4.67

181.07

2.5

2.0

950.71

626.34

ug/l

0.59

431

996

(3013115) Eosinophils [#/volume] in Blood

2509

15505

2.47

179.50

8.5

5.6

0.19

0.20

e9/l

0.76

2267

13420

(3001604) Monocytes [#/volume] in Blood

2449

14972

2.46

179.42

8.0

5.4

0.65

0.60

e9/l

15.23

2203

12805

(3042936) Bacteria identified in Isolate by Culture

1058

4347

2.90

177.29

2.9

1.9

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

547

1500

4.03

175.75

5.1

2.5

1.26

1.21

0.51

547

1491

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1096

4613

2.84

175.33

2.8

2.0

30.56

30.05

1.55

1063

4442

(3019198) Lymphocytes [#/volume] in Blood

2486

15406

2.44

175.12

8.1

5.5

1.71

1.90

e9/l

5.87

2270

13458

(3007853) Bacteria identified in Skin by Aerobe culture

939

3661

3.00

172.70

2.3

1.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

467

1158

4.40

171.63

7.0

3.7

1.51

1.36

mmol/l

2.09

460

1147

(40767503) Oxygen content in Capillary blood by calculation

347

674

5.51

170.77

4.2

2.2

15.80

16.13

0.68

217

319

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

534

1474

3.99

169.78

5.0

2.5

0.71

0.65

3.77

534

1468

(36304419) Bacteria [Presence] in Urine

1664

8712

2.48

169.48

5.1

3.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

677

2198

3.47

169.14

5.4

3.4

122.24

91.00

ng/l

6.64

569

1824

(3015377) Calcium [Moles/volume] in Serum or Plasma

1942

10939

2.41

167.53

4.5

3.2

2.32

2.35

mmol/l

12.56

1719

9406

(3028626) Oxygen [Partial pressure] in Capillary blood

384

831

4.97

166.97

5.7

3.5

8.19

8.29

kpa

0.45

375

804

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

624

1939

3.59

166.74

11.6

7.3

0.71

0.68

0.74

617

1929

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

621

1949

3.55

163.25

11.6

7.2

1.44

1.37

0.97

614

1940

(3027273) Bicarbonate [Moles/volume] in Venous blood

544

1577

3.80

160.96

6.1

2.9

24.54

25.21

mmol/l

2.85

519

1530

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

526

1492

3.87

160.58

7.1

3.4

48.72

48.00

0.25

516

1470

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

529

1519

3.83

158.60

1.9

1.7

1.62

1.50

g/l

1.93

453

1288

(3013650) Neutrophils [#/volume] in Blood by Automated count

2668

17550

2.36

156.94

14.4

8.3

4.88

4.20

e9/l

29.05

2449

15165

(3021901) Oxygen saturation in Capillary blood

310

589

5.59

156.05

4.4

2.5

—

(3010421) pH of Blood

379

859

4.74

155.63

7.0

3.9

7.42

1.23

341

773

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2213

13488

2.31

155.43

2.7

2.0

88.27

93.21

pmol/l

5.52

1399

6963

(3021960) Folate [Moles/volume] in Serum or Plasma

1504

7791

2.43

153.81

2.0

1.5

18.47

20.44

nmol/l

4.60

1332

6517

(3012501) Base excess in Blood by calculation

346

736

5.02

153.27

7.0

4.0

2.77

2.58

mmol/l

0.51

240

494

(3013290) Carbon dioxide [Partial pressure] in Blood

346

737

5.02

153.02

7.0

4.0

4.90

5.00

kpa

1.40

337

719

(3027315) Oxygen [Partial pressure] in Blood

347

741

5.00

153.00

7.0

4.0

8.48

8.37

kpa

0.50

337

723

(3019069) Monocytes/100 leukocytes in Blood

2272

14126

2.28

150.50

8.7

6.0

8.75

8.78

0.19

2154

13012

(3022096) Basophils/100 leukocytes in Blood

2211

13616

2.28

149.59

8.3

5.8

0.59

0.65

5.90

2090

12519

(3006504) Eosinophils/100 leukocytes in Blood

2255

14050

2.26

147.65

8.4

5.7

2.53

2.86

9.63

2136

12923

(3020630) Protein [Mass/volume] in Serum or Plasma

728

2677

3.07

146.67

2.5

2.4

63.68

66.13

g/l

11.27

656

2357

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1617

8810

2.33

145.72

4.5

3.0

47.47

35.25

u/l

0.66

1525

8249

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3288

24094

2.52

145.44

13.8

6.9

90.14

80.84

u/l

13.66

3145

22376

(3002030) Lymphocytes/100 leukocytes in Blood

2295

14468

2.25

145.15

8.6

5.9

22.94

27.01

52.00

2176

13365

(3035350) Ketones [Presence] in Urine by Test strip

2364

15163

2.23

142.21

6.4

3.8

0.00

estimate

0.05

659

3106

(3021601) Nitrite [Presence] in Urine by Test strip

2357

15136

2.22

140.90

7.9

5.0

0.00

estimate

0.50

640

2864

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

336

748

4.79

140.75

5.8

4.9

2.08

1.51

mg/l

15.65

318

671

(3037467) Urinalysis macro (dipstick) panel - Urine

3051

21789

2.36

140.36

7.4

4.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

774

3020

2.90

139.71

3.5

2.3

5.52

7.14

ug/l

2.38

645

2542

(3009261) Glucose [Presence] in Urine by Test strip

2375

15352

2.21

138.95

6.4

3.8

0.01

0.00

estimate

0.44

615

2796

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2011

12279

2.19

134.44

3.2

2.1

73.88

79.11

nmol/l

11.51

1808

10641

(3018010) Neutrophils/100 leukocytes in Blood

2236

14233

2.18

134.44

8.2

5.6

61.48

57.85

34.28

2117

13141

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

511

1614

3.46

131.79

10.5

7.4

23.87

24.34

mmol/l

1.54

479

1533

(3025941) Bacteria identified in Stool by Culture

487

1513

3.50

128.77

1.5

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

1548

8637

2.23

128.26

7.0

4.1

0.02

0.00

estimate

1.05

565

2730

(3020891) Body temperature

456

1363

3.62

127.89

9.9

4.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

408

1143

3.84

125.83

3.7

2.8

0.32

0.35

u/ml

0.56

256

638

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

781

3228

2.73

125.33

3.5

2.8

9.13

9.79

umol/l

0.35

655

2805

(3044640) Blood type and Crossmatch panel - Blood

1681

9784

2.17

124.42

3.7

2.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1227

6301

2.32

123.30

2.3

1.7

1.68

1.40

mg/l

1.09

1007

4791

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

808

3431

2.67

122.70

6.7

3.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

376

1012

3.97

122.66

7.6

3.8

3.93

3.91

mmol/l

0.22

371

1007

(3004588) Protein electrophoresis panel - Serum or Plasma

600

2190

3.02

121.12

2.1

2.3

—

(3024928) Oxygen saturation in Venous blood

272

582

4.92

119.19

3.3

3.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1340

7244

2.23

118.19

2.0

1.7

464.16

24697271.64

pmol/l

4.40

1099

5855

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2152

14250

2.01

108.02

3.7

2.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

530

1920

3.01

107.83

2.3

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

994

4973

2.30

103.83

4.6

2.9

3.66

2.30

e6/l

2.68

645

2761

(3006184) Hemoglobin [Mass/volume] in Capillary blood

281

692

4.27

103.09

3.4

2.1

124.11

128.72

g/l

2.05

245

499

(3009508) Creatinine [Moles/volume] in Urine

1570

9407

2.05

103.05

4.2

3.0

6.84

7.49

mmol/l

7.11

1313

7754

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1863

11898

1.99

101.84

7.0

4.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

653

2736

2.63

100.42

2.5

1.7

1.79

1.50

7.80

539

2373

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

239

530

4.71

100.12

6.8

4.5

502.86

3569.64

iu/ml

0.45

(3015736) pH of Urine

1884

12159

1.97

99.14

5.6

3.5

6.16

5.80

1.43

649

(3022313) Gas panel - Capillary blood

449

1554

3.11

98.60

7.5

3.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1160

6291

2.15

98.59

4.1

3.1

2.48

2.46

mmol/l

6.19

1017

5467

(3017181) Myelocytes/100 leukocytes in Blood

616

2529

2.67

98.58

4.6

4.0

1.15

0.96

0.98

306

894

(3026493) Urate [Moles/volume] in Serum or Plasma

1367

7890

2.07

98.50

4.1

2.6

4759.30

5406.98

umol/l

0.16

1186

6720

(40758558) Short blood count panel - Blood

1336

7672

2.07

97.41

10.7

6.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1557

9453

2.01

97.23

5.1

3.5

20.68

7.68

mg/mmol

10.42

1123

5887

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

338

990

3.62

97.05

2.3

3.2

58.49

51.46

mg/l

0.15

244

804

(3034860) Kappa light chains.free [Mass/volume] in Serum

337

992

3.60

96.01

2.3

3.2

60.14

63.80

mg/l

0.16

242

800

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

289

767

3.97

95.70

1.6

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

328

958

3.62

94.53

2.4

3.2

1.75

3.26

ratio

1.09

(40760888) Immunoglobulin light chains.free panel - Serum

283

753

3.95

93.34

2.2

3.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2514

18167

1.92

91.52

5.5

3.0

83.81

50.81

u/l

18.49

2344

16528

(3033658) Prothrombin time (PT) actual/Normal

1294

7488

2.04

91.33

7.5

3.8

83.82

85.16

0.99

1249

7297

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

278

746

3.91

90.57

1.7

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

613

2616

2.56

90.19

2.0

1.5

—

(3021589) Normoblasts [#/volume] in Blood

1990

13372

1.90

90.17

21.7

9.2

0.00

e9/l

0.23

1731

10891

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

199

414

4.99

89.90

6.8

6.3

12.73

11.94

mg/l

1.31

181

373

(3021440) Promyelocytes/100 leukocytes in Blood

578

2405

2.62

89.56

4.7

4.0

0.14

0.10

0.79

272

775

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

620

2670

2.54

89.46

8.5

3.2

1.21

1.23

mmol/l

5.50

576

2288

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

209

459

4.73

88.50

1.7

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

309

908

3.59

88.13

2.1

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

506

1991

2.75

87.52

2.6

2.8

10.41

10.68

g/l

0.55

456

1798

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

234

569

4.29

87.12

1.7

1.6

—

(3012516) Albumin [Mass/volume] in Urine

1461

8943

1.96

86.98

4.2

3.1

336.08

355.78

mg/l

0.07

1086

5692

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

601

2616

2.51

84.49

4.2

2.4

44.76

57.93

u/l

0.29

515

2229

(3013707) Erythrocyte sedimentation rate by Westergren method

2936

22639

1.92

84.12

5.5

3.9

20.59

13.40

mm/h

59.25

2708

20572

(3000012) Reticulocyte production index

211

489

4.48

83.54

2.5

2.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

420

1533

2.93

83.50

1.9

1.23

1.47

g/l

1.17

384

1372

(3002179) Metamyelocytes/100 leukocytes in Blood

548

2302

2.58

82.94

4.5

3.9

0.79

0.71

0.28

259

759

(3016038) Potassium [Moles/volume] in Urine

100

111

9.20

82.06

2.4

1.3

35.45

36.86

mmol/l

0.18

(3025159) Blasts/100 leukocytes in Blood

538

2255

2.58

81.74

4.7

4.1

0.03

0.28

1.11

229

634

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

200

452

4.59

81.71

6.5

2.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1085

6105

2.04

81.27

6.5

3.7

263.58

604.54

ng/l

1.35

941

5062

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

238

621

4.00

80.52

1.7

1.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

987

5394

2.07

79.90

4.1

2.7

1.49

1.17

e6/l

1.85

632

3150

(3000570) Elastase.pancreatic [Mass/mass] in Stool

281

835

3.53

78.65

1.5

1.4

238.82

275.60

ug/g

2.05

173

493

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3665

30839

2.23

78.46

42.1

14.5

27.45

26.40

mg/l

1.31

3427

24614

(3008295) Osmolality of Serum or Plasma

132

213

6.36

78.29

1.5

1.4

279.71

285.29

mosm/kgh2o

1.28

111

142

(3026250) Tacrolimus [Mass/volume] in Blood

10.43

75.69

52.0

30.5

6.93

7.35

ug/l

0.49

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

414

1580

2.79

75.52

13.4

8.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

177

387

4.73

75.29

6.4

4.5

352.66

342.11

umol/l

0.36

150

325

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2871

22437

1.83

73.30

4.8

3.6

15.27

14.96

pmol/l

6.73

2616

19808

(3020191) Ethanol [Moles/volume] in Serum or Plasma

115

173

6.80

72.94

2.1

1.2

1.49

1.29

promille

0.50

133

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

182

418

4.50

72.83

4.9

3.0

879.68

1699.97

u/ml

0.40

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1238

7528

1.90

72.66

3.6

2.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

170

377

4.65

71.05

1.7

1.5

—

(3013512) EKG study

1489

9709

1.81

69.25

6.3

3.8

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

336

1203

2.94

68.83

1.4

1.5

4.86

19.64

u/ml

1.62

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

202

532

3.93

67.37

1.6

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

162

363

4.60

66.83

5.7

6.0

7.40

7.09

mmol/l

0.47

152

291

(3041096) Erythrocytes [Presence] in Urine by Automated

1269

7982

1.83

65.74

6.2

3.4

—

(40761536) Microorganisms panel - Urine sediment

578

2746

2.28

65.74

7.5

3.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

360

1372

2.77

65.59

8.4

4.0

23.99

24.83

mmol/l

4.42

338

1256

(3020876) Protein [Mass/time] in 24 hour Urine

144

301

4.91

64.61

2.9

2.4

1.74

1.40

g/24h

0.48

150

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

335

1252

2.82

63.29

7.3

4.7

1.66

1.62

0.28

321

1168

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

137

282

4.98

62.58

1.7

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

173

435

4.10

61.47

1.6

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

643

3273

2.13

61.32

2.1

1.5

—

(3037756) Immunofixation for Serum or Plasma

226

686

3.42

61.03

1.3

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

206

591

3.61

60.66

3.7

3.5

59.57

58.43

0.55

206

591

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

8.77

60.33

3.6

2.6

169.29

132.28

umol/l

0.22

(46235355) HIV 1 and 2 tests - Meaningful Use set

716

3844

2.03

59.01

2.1

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

324

1234

2.76

58.97

7.5

4.7

0.82

0.89

2.52

312

1149

(40761535) Cells panel - Urine sediment

586

2920

2.16

58.87

5.8

3.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

179

478

3.86

58.51

1.6

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

271

941

3.01

58.47

1.6

295.38

203.02

titre

0.35

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

245

804

3.17

58.26

3.5

2.8

3.48

3.52

g/l

0.16

234

762

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

226

715

3.28

57.09

2.4

2.1

192.81

98.72

ug/min

1.69

134

399

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

165

424

4.01

56.90

1.6

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1142

7221

1.79

56.68

5.9

3.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

646

3432

2.04

54.48

4.4

4.0

14.47

23.38

ug/l

1.09

553

2847

(3019150) Specific gravity of Urine by Refractometry

1096

6983

1.76

52.33

6.8

4.3

1.02

kg/l

0.91

120

1057

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3267

27629

1.74

52.05

6.0

4.4

2.13

2.06

mu/l

0.38

3002

24553

(3034770) Mitochondria Ab [Titer] in Serum

202

645

3.24

50.22

1.3

1.2

376.00

1129.50

titre

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

245

882

2.88

49.45

3.6

3.2

0.93

0.82

nmol/l

1.46

192

664

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2112

16119

1.61

49.43

3.3

2.6

—

(3036489) Thrombin time

260

969

2.79

49.18

3.1

2.3

22.88

21.45

1.30

230

874

(3019550) Sodium [Moles/volume] in Serum or Plasma

3667

32267

1.90

48.94

51.1

16.7

138.89

139.68

mmol/l

41.51

3582

31210

(3007566) Smooth muscle Ab [Titer] in Serum

200

648

3.19

48.53

1.3

1.2

72.73

91.76

titre

0.66

(3011985) Renin [Units/volume] in Plasma

119

271

4.49

48.11

1.9

1.3

139.28

52.61

mu/l

1.35

100

238

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

100

198

5.15

47.78

1.8

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

178

543

3.38

47.64

3.2

3.8

1.67

1.55

0.18

157

471

(3037522) Nuclear Ab [Titer] in Serum

613

3346

1.97

47.44

1.4

1.3

430.73

503.50

titre

0.53

151

715

(3023103) Potassium [Moles/volume] in Serum or Plasma

3665

32342

1.87

47.09

51.1

16.8

4.02

3.99

mmol/l

8.34

3577

31216

(40768797) Stomach Pathology biopsy report

686

3904

1.90

46.83

1.4

1.2

—

(40768446) Kidney Pathology biopsy report

7.91

46.80

2.0

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

231

835

2.87

46.25

1.6

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

100

204

4.99

46.17

1.8

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

832

5056

1.80

45.93

1.8

1.4

3.00

2.56

g/l

4.37

565

2916

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

278

1113

2.60

45.64

2.5

2.7

—

(3047181) Lactate [Moles/volume] in Blood

246

926

2.76

45.63

7.9

5.5

1.60

1.34

mmol/l

1.57

210

819

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

207

711

3.01

45.43

1.5

0.25

0.24

g/l

1.15

192

677

(3037121) Protein [Mass/volume] in Urine

270

1069

2.63

45.33

4.7

3.1

0.45

0.28

g/l

1.90

159

411

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

1219

2.51

44.87

1.8

2.2

7.64

7.38

g/l

1.63

250

1055

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

211

738

2.95

44.84

1.5

1.15

1.16

g/l

0.23

198

701

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

231

849

2.82

44.83

1.5

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

147

5.74

44.79

2.9

2.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

218

778

2.90

44.67

3.6

2.6

88.87

89.24

0.07

209

752

(3017569) Oxygen content in Arterial blood

151

5.65

44.63

2.4

2.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

293

1217

2.51

44.54

1.8

2.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

120

293

4.18

44.35

1.4

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

563

3052

1.97

44.26

3.0

2.2

223.42

148.85

ug/g

3.11

447

2360

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

292

1216

2.50

44.14

1.8

2.2

3.82

3.69

g/l

0.57

249

1056

(3042733) HLA Ab [Presence] in Serum

8.83

44.01

5.7

4.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

230

855

2.78

43.68

1.5

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

277

1134

2.54

43.40

1.8

2.2

3.13

2.99

g/l

1.28

233

973

(42529406) Shigella sp [Presence] in Stool by Culture

230

860

2.77

43.19

1.5

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

201

702

2.95

42.82

1.7

1.5

—

(3012565) Volume of 24 hour Urine

113

6.37

42.69

2.4

2.6

1820.63

1896.68

0.11

(40761511) CBC panel - Blood by Automated count

3593

31790

1.77

42.09

39.1

13.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

255

1022

2.59

41.73

2.2

2.3

0.95

1.26

g/l

0.35

209

846

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

200

711

2.90

41.26

3.7

3.3

589.18

877.89

u/ml

0.22

183

647

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

210

769

2.82

41.01

1.6

1.3

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

13.11

40.83

2.2

3.0

37.76

25.34

mg/l

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

218

4.58

40.81

1.7

1.4

—

(3019977) pH of Arterial blood

168

5.14

40.71

3.6

2.3

7.42

7.43

0.45

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

226

864

2.70

40.64

2.0

2.2

0.01

0.05

g/l

1.14

195

772

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

209

769

2.80

40.45

1.6

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

310

1381

2.34

40.31

3.0

3.98

4.44

pmol/l

4.86

268

1205

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

193

4.79

40.16

1.7

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

158

501

3.24

39.72

2.2

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

107

6.25

38.98

28.3

26.3

116.17

120.73

ug/l

0.18

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

195

4.69

38.72

1.7

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

471

2513

1.98

38.49

4.6

2.5

46.96

63.70

ml/min/173m2

21.03

284

997

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

157

506

3.18

38.43

3.7

1.7

0.99

0.78

nmol/l

1.52

129

420

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

147

459

3.28

37.90

1.7

1.2

271.80

275.63

u/ml

0.05

101

268

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

153

490

3.20

37.84

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

153

490

3.20

37.84

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

104

258

4.11

37.65

1.3

478.96

281.93

pmol/l

0.89

223

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

144

451

3.27

36.95

2.2

1.4

109.46

118.53

u/ml

0.39

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

153

498

3.15

36.84

1.6

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

191

715

2.75

35.77

3.9

2.8

216.33

193.20

2.32

177

680

(40757494) Bilirubin.total [Moles/volume] in Blood

177

4.70

35.45

3.2

2.2

17.95

57.40

umol/l

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.35

35.45

3.3

2.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

262

1149

2.36

35.25

1.9

2.2

9.98

10.49

g/l

0.96

214

980

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.35

35.11

5.1

5.5

—

(3002385) Erythrocyte distribution width [Ratio]

3002

25822

1.53

34.74

45.5

16.8

15.64

15.19

4.71

2952

25184

(3003434) Protein [Mass/volume] in Pleural fluid

154

522

3.02

34.59

1.6

1.4

27.52

31.50

g/l

3.48

135

467

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

6.40

34.55

3.2

2.4

—

(3000494) Fungus identified in Specimen by Culture

566

3325

1.81

34.16

1.7

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

227

949

2.47

33.95

1.9

2.0

34.94

37.24

g/l

5.42

183

784

(3004451) EKG impression Narrative

126

5.38

33.94

1.5

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

138

448

3.15

33.39

1.2

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

110

310

3.61

33.28

2.4

2.7

—

(3012441) Differential panel - Pleural fluid

127

393

3.30

33.25

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

203

813

2.57

33.23

2.0

2.2

0.00

g/l

0.50

174

724

(21494890) Protein electrophoresis panel - 24 hour Urine

108

301

3.65

33.22

2.2

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

166

601

2.83

33.11

1.8

1.6

—

(3044889) 12 lead EKG panel

2577

21597

1.48

32.86

6.0

3.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

286

1344

2.21

32.65

2.5

1.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

527

3070

1.82

32.62

4.2

2.9

365.46

245.09

ng/l

4.49

478

2770

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

305

1475

2.15

32.39

2.6

1.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

867

5809

1.62

32.01

1.4

1.3

1.27

1.87

u/ml

0.79

253

1453

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

198

799

2.55

31.91

2.0

2.2

0.00

g/l

-0.00

172

721

(44816559) Phosphatidylethanol [Mass/volume] in Blood

133

434

3.13

31.91

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

122

378

3.29

31.88

1.9

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

145

4.89

31.81

2.0

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

145

4.89

31.81

2.0

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

241

3.92

31.76

1.4

1.2

1.39

1.42

nmol/l

0.09

212

(3016750) Collection duration of Urine

161

4.66

31.71

2.2

1.9

503.98

488.93

min

0.47

108

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

121

376

3.28

31.48

1.9

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

122

382

3.26

31.35

1.9

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

113

340

3.39

30.95

1.6

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

113

340

3.39

30.95

1.6

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

141

4.88

30.87

2.4

2.8

88.56

95.85

0.85

134

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

122

387

3.21

30.69

1.9

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

120

377

3.25

30.67

1.9

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

120

377

3.25

30.67

1.9

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

216

933

2.38

30.05

5.4

3.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

129

433

3.04

29.50

1.4

1.3

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

110

5.33

29.14

18.1

10.6

0.70

0.61

mmol/l

1.67

104

(3011648) Oxygen content in Venous blood

198

4.10

29.11

3.0

4.1

10.19

10.83

0.66

198

(4035726) Immunohistochemistry procedure

460

2674

1.81

28.50

1.5

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3589

32579

1.60

28.45

19.1

9.8

24.99

25.45

u/l

0.61

3472

30950

(3004775) Volume in Urine collected for unspecified duration

238

3.75

28.32

2.2

2.1

843.42

613.66

1.86

140

(3004716) Salmonella sp identified in Stool by Organism specific culture

264

1272

2.15

28.26

1.4

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

322

1671

2.00

28.23

1.5

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

183

756

2.48

28.08

6.1

3.0

1.85

1.69

mmol/l

1.13

178

739

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

231

1060

2.25

27.92

2.2

1.7

37.06

39.27

u/l

0.70

199

905

(40768806) Pleura Pathology biopsy report

120

399

3.06

27.91

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

128

442

2.95

27.86

1.9

1.6

—

(3022145) Colonoscopy Study observation

521

3161

1.74

27.83

1.6

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

260

3.59

27.76

4.0

2.7

66.69

29.49

mg/l

0.86

189

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

151

573

2.69

27.57

1.3

1.5

4.04

3.78

mmol/l

1.58

131

537

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

163

649

2.57

27.02

1.4

1.5

549.75

565.13

mg/l

0.08

148

612

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

270

3.50

26.96

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

270

3.50

26.96

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

270

3.50

26.96

1.5

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

275

3.47

26.93

1.3

1.2

68.65

66.34

u/l

0.09

239

(3048929) Epstein Barr virus Ab [Presence] in Serum

177

736

2.46

26.78

1.7

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

160

4.30

26.46

1.6

1.4

68.48

66.83

0.13

126

(3042631) Mycobacterium sp identified in Specimen

129

466

2.82

25.88

2.5

2.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

105

338

3.16

25.82

1.4

1.3

6.67

6.12

mmol/l

1.34

308

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

235

3.63

25.76

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

115

391

2.99

25.75

1.5

1.6

0.69

0.89

g/l

1.02

289

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.87

25.68

4.3

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.87

25.68

4.3

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

145

560

2.64

25.58

1.5

1.7

426.50

709.22

e6/l

0.39

124

466

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

145

560

2.64

25.58

1.4

1.6

27.90

13.70

e6/l

0.27

115

449

(3009542) Hematocrit [Volume Fraction] of Blood

3707

34106

1.61

25.56

57.5

21.2

37.48

39.98

25.65

3442

31413

(3008116) Ketones [Moles/volume] in Urine by Test strip

7.55

25.45

2.6

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

178

4.04

25.42

1.3

1.2

2.36

2.11

mmol/l

0.57

169

(3007461) Platelets [#/volume] in Blood

3707

34120

1.60

25.35

57.1

21.1

246.95

242.73

e9/l

2.69

3627

32943

(3016650) Hepatitis A virus Ab [Presence] in Serum

113

384

2.99

25.33

1.1

—

(3010813) Leukocytes [#/volume] in Blood

3708

34137

1.60

25.27

57.1

21.1

7.53

6.85

e9/l

55.20

3625

32807

(3000963) Hemoglobin [Mass/volume] in Blood

3708

34143

1.60

25.18

57.7

21.3

124.55

134.09

g/l

209.40

3635

33373

(3024731) MCV [Entitic volume]

3707

34132

1.60

25.17

56.9

21.1

92.16

91.34

17.65

3632

33360

(3035941) MCH [Entitic mass]

3706

34133

1.60

24.99

56.8

21.0

30.35

30.36

0.18

3631

33360

(3026361) Erythrocytes [#/volume] in Blood

3706

34136

1.60

24.95

57.1

21.1

4.15

4.44

e12/l

166.22

3614

32820

(3022493) Free Hemoglobin [Mass/volume] in Plasma

128

4.58

24.48

3.0

3.4

62.39

68.82

mg/l

0.27

(1001926) Buprenorphine [Presence] in Urine by Screen method

138

532

2.65

24.45

2.3

2.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

180

791

2.33

24.10

1.3

1.2

—

(3016879) Cocaine [Presence] in Urine

153

631

2.48

23.59

2.3

2.2

—

(3011288) Drugs identified in Urine by Screen method

125

467

2.73

23.56

2.6

2.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

158

4.10

23.42

1.5

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

133

515

2.63

23.37

1.1

1.3

23.93

51.50

u/l

2.24

109

437

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

103

349

3.00

23.23

1.4

1.3

280.03

429.03

u/l

0.65

329

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3125

27928

1.43

23.21

8.7

5.6

43.92

40.00

mmol/mol

52.10

2858

25126

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

330

3.05

22.98

1.5

1.6

—

(3036180) Methadone [Presence] in Urine

5.41

22.57

2.0

—

(3006653) Thiamine [Moles/volume] in Blood

121

4.51

22.39

1.3

1.1

149.43

141.03

nmol/l

0.37

121

(3044290) Cell count panel - Cerebral spinal fluid

130

509

2.60

22.35

1.2

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

274

3.22

22.23

1.2

9.29

12.56

u/l

1.81

247

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

228

1146

2.04

21.81

3.1

3.3

1194.39

2254.23

u/ml

0.34

199

966

(3000764) Benzodiazepines [Presence] in Urine

156

673

2.37

21.80

2.3

2.1

—

(4062490) Immunoglobulin typing, IgG

243

3.34

21.67

1.5

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

174

791

2.25

21.53

1.7

1.5

0.20

10.85

iu/ml

0.75

171

(3001893) Eosinophils/100 leukocytes in Pleural fluid

125

4.36

21.51

1.6

1.4

0.88

2.83

1.88

101

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

250

3.28

21.40

1.7

1.4

15.41

13.01

u/l

1.20

237

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

308

3.03

21.22

1.5

1.6

—

(3028300) Cannabinoids [Presence] in Urine

156

683

2.33

21.09

2.3

2.1

—

(3027008) Opiates [Presence] in Urine

155

678

2.33

21.00

2.3

2.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

176

3.73

20.96

1.7

1.5

12.60

6.82

u/l

0.73

141

(3027135) IgG subclass 1 [Mass/volume] in Serum

244

3.28

20.85

1.4

1.3

6.21

6.67

g/l

0.49

161

(3028192) IgG subclass 2 [Mass/volume] in Serum

244

3.28

20.85

1.4

1.3

2.42

2.93

g/l

1.78

161

(3024139) IgG subclass 3 [Mass/volume] in Serum

244

3.28

20.85

1.4

1.3

0.35

0.42

g/l

1.16

161

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

270

3.15

20.77

1.4

1.3

—

(3039000) Anion gap in Blood

151

657

2.35

20.71

10.3

6.3

12.13

11.28

mmol/l

1.65

141

579

(3018572) Chloride [Moles/volume] in Blood

151

658

2.34

20.64

10.3

6.3

104.91

105.14

mmol/l

0.19

141

580

(3023199) Leukocytes [#/volume] in Pleural fluid

118

465

2.58

20.05

1.5

1250.06

1871.54

e6/l

1.12

345

(3049717) Cytology report of Urine Cyto stain

258

1395

1.90

20.00

2.5

2.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

304

2.97

19.84

3.1

2.8

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

154

689

2.28

19.81

2.2

1.8

13.32

11.69

mg/l

1.02

138

637

(3006922) Hepatitis E virus Ab [Presence] in Serum

157

3.80

19.52

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

164

3.70

19.11

3.5

3.1

—

(3038515) Glucose [Moles/volume] in Venous blood

157

722

2.22

18.92

6.5

3.1

8.10

7.75

mmol/l

0.65

151

707

(3014271) Vancomycin [Susceptibility]

194

3.44

18.87

3.7

3.2

—

(3024932) HLA-DR beta [Type]

5.10

18.80

1.0

1.1

—

(3011412) CD3 cells [#/volume] in Blood

255

3.10

18.78

1.9

2.5

1.01

1.14

e9/l

0.73

228

(3023419) Bacteria identified in Sputum by Culture

119

487

2.48

18.71

2.2

2.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.59

18.65

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

104

402

2.63

18.40

1.1

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

100

379

2.68

18.40

3.0

4.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

145

654

2.26

18.32

1.4

1.3

—

(3024471) HLA-A [Type]

4.97

18.27

1.0

—

(3035880) pH of Pleural fluid

199

3.35

18.15

1.4

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1888

0.34

18.08

1.4

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

161

3.64

18.08

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.73

18.03

1.2

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3135

28464

1.37

17.99

39.1

13.6

66.94

76.08

ml/min/173m2

68.06

2812

23364

(3027944) Amphetamines [Presence] in Urine

147

672

2.23

17.99

2.4

2.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

355

2.71

17.98

2.9

3.8

62.34

55.08

2.05

291

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

158

3.64

17.81

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

24.11

17.29

2.6

2.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

312

2.79

17.23

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

227

3.12

17.12

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

238

3.06

17.04

2.5

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

620

4380

1.48

17.01

20.0

7.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

127

3.89

16.86

1.2

1.1

4.43

3.78

iu/ml

—

(3013727) Leukocytes other/100 leukocytes in Blood

106

4.18

16.70

3.8

3.6

55.72

55.34

0.03

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

3.75

16.69

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

171

3.42

16.54

6.1

2.6

—

(3045414) Leukocytes [Presence] in Urine

235

1311

1.84

16.53

2.6

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

129

3.83

16.50

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

127

567

2.28

16.47

1.4

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

5.57

16.47

1.2

1.1

60.61

192.93

nmol/24h

0.61

(21494755) Public health laboratory ask at order entry panel

1715

0.35

16.39

1.2

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

350

2.63

16.31

1.1

1.83

1.52

g/l

6.05

310

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

144

3.64

16.30

1.3

1.2

39.28

22.43

u/l

0.90

115

(3044927) Protein electrophoresis panel - Urine

323

2.70

16.15

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

105

435

2.45

16.13

1.5

1.4

26770.45

60651.11

e6/l

0.95

266

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1240

0.24

16.03

1.3

1.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

146

3.59

15.98

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

146

3.59

15.98

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

258

2.90

15.98

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

103

425

2.46

15.97

1.3

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

186

3.26

15.82

2.2

2.4

—

(3003694) ABO and Rh group [Type] in Blood

1016

7932

1.37

15.77

1.5

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

312

2.69

15.57

6.0

2.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

26.36

15.57

3.4

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

171

877

1.99

15.52

1.4

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

159

795

2.04

15.49

1.8

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

154

3.47

15.48

1.3

1.2

141.79

97.05

u/l

0.94

127

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

199

3.15

15.46

1.5

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

7.00

15.25

9.2

10.4

5.50

5.97

mmol/l

0.16

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

4.43

15.17

1.1

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

387

2.49

15.15

1.8

1.7

3.53

4.85

mmol/24h

3.56

331

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

182

3.22

15.02

2.3

2.6

20.25

19.97

nmol/l

0.06

172

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3208

29511

1.34

14.94

5.8

4.5

6.49

5.98

mmol/l

34.09

2835

26071

(3017732) Neutrophils [#/volume] in Blood

319

1998

1.64

14.87

4.0

2.9

7.68

5.58

e9/l

0.47

231

1525

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

211

3.01

14.63

1.3

1.2

100.00

179.75

titre

0.81

(3002079) Sodium [Moles/time] in 24 hour Urine

4.80

14.46

1.2

1.4

131.16

146.99

mmol/24h

0.36

(3033705) Calcium.ionized [Moles/volume] in Venous blood

104

454

2.32

14.26

4.3

2.3

—

(3045788) Cell count panel - Pleural fluid

363

2.48

14.18

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

179

963

1.90

14.14

1.2

0.27

0.69

u/ml

1.00

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

238

2.84

14.03

2.0

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.35

14.02

1.1

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.29

13.81

1.2

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

34.12

13.49

1.0

—

mmol/l

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

150

773

1.97

13.47

1.9

1.7

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

12.84

13.38

3.3

4.8

1.77

2.10

mg/l

0.19

(3019225) pH of Specimen

491

3467

1.47

13.34

8.8

4.0

—

(3003129) Base excess in Capillary blood by calculation

4.47

13.29

2.5

2.0

-0.91

1.73

mmol/l

1.37

(1761482) Bacteria [#/volume] in Urine by Culture

176

962

1.86

13.26

6.4

4.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

306

2.54

12.99

1.5

1.3

0.18

0.32

nmol/l

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

152

3.25

12.97

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

211

1227

1.76

12.96

1.2

1.1

311.00

227.93

titre

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

28.43

12.94

6.3

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

200

2.93

12.84

2.0

2.4

12.43

16.23

2.26

194

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

296

2.56

12.84

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

268

2.64

12.74

1.5

1.3

—

nmol/l

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

337

2.43

12.42

4.5

3.0

10.62

24.37

nmol/l

0.39

329

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

199

2.89

12.36

1.2

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

316

2.46

12.17

1.5

18.81

27.66

1.58

202

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.37

12.14

1.1

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

244

1507

1.66

12.03

1.3

375.04

234.51

u/ml

0.83

225

1387

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

113

548

2.09

12.03

1.5

1.7

5.47

4.19

iu/l

0.32

164

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

392

2.30

12.02

1.2

1.1

231.44

106.28

iu/ml

0.48

(3014148) Varicella zoster virus Ab [Titer] in Serum

253

2.63

12.00

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

254

2.62

11.91

1.2

1.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

4.00

11.90

2.1

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

273

2.55

11.78

1.6

1.3

—

(40757373) Influenza virus identified in Isolate

4.25

11.71

1.4

1.2

—

(3022689) Creatine [Moles/volume] in Urine

4.52

11.40

1.7

1.4

—

(3014891) Appearance of Pleural fluid

4.66

11.40

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

4.05

11.38

2.3

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

198

2.80

11.30

2.2

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

189

2.83

11.09

2.1

1.7

2.47

3.50

u/field

0.36

126

(3017704) Immunofixation for Urine

159

2.98

10.82

1.1

1.5

—

(3045424) Erythrocytes [Presence] in Urine

103

504

2.07

10.75

1.7

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

149

3.04

10.75

1.2

171.97

298.22

u/l

1.24

141

(3033799) Differential panel - Peritoneal fluid

3.69

10.66

2.3

1.8

—

(3020393) Adenovirus Ag [Presence] in Stool

5.02

10.51

1.4

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.70

10.39

1.2

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

185

2.78

10.36

1.6

2.7

412.03

541.09

e6/l

1.23

156

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

180

2.80

10.31

1.7

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

113

581

1.97

10.30

3.1

2.3

298.64

4292.11

u/l

4.87

236

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.02

10.21

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

183

2.75

10.00

1.9

2.4

604.49

642.29

e6/l

0.21

177

(21494814) CD8 cells/100 lymphocytes in Specimen

3.45

10.00

2.1

1.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

290

2.37

9.95

1.5

1.7

37.45

28.10

u/ml

0.41

(3009214) Lutropin [Units/volume] in Serum or Plasma

115

603

1.93

9.92

1.5

11.32

8.83

u/l

1.02

483

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

131

3.07

9.76

1.2

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

331

2.26

9.71

3.5

3.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.74

9.58

1.3

1.2

12.60

15.00

g/l

0.61

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

446

2.06

9.50

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

200

2.62

9.47

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

161

2.81

9.41

2.2

2.3

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

186

2.65

9.17

4.6

3.3

244.35

168.26

nmol/l

0.43

181

(40768441) Liver Pathology biopsy report

187

2.64

9.08

1.7

1.3

—

(3000330) Specific gravity of Urine by Test strip

251

1676

1.53

8.95

5.6

3.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

138

2.92

8.95

1.5

1.3

1.11

1.10

nmol/l

0.02

112

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

112

3.14

8.90

1.0

1.3

16.40

588.58

ug/l

1.12

(3032057) Clostridioides difficile [Presence] in Stool

3.72

8.87

2.6

1.7

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.92

8.85

1.6

1.3

14.29

5.32

1.02

(3030313) Adrenal Ab [Titer] in Serum

12.54

8.85

1.3

1.0

—

(3045142) Bone marrow Pathology biopsy report

338

2.18

8.85

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

123

3.03

8.83

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

3.86

8.67

1.4

1.3

20.81

29.19

g/l

1.40

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

3.62

8.54

1.3

1.4

0.80

27.69

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

205

2.51

8.53

1.4

1.2

—

(3023410) Appearance of Cerebral spinal fluid

243

2.36

8.41

1.4

2.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

219

2.44

8.37

1.3

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

7.85

8.35

2.1

1.6

15.78

22.38

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

7.06

8.23

2.3

1.7

59.23

53.44

0.21

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

179

2.59

8.23

1.7

2.7

0.14

0.23

e9/l

2.88

153

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.91

8.14

1.1

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

152

2.71

8.07

1.3

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.18

8.07

2.0

1.7

582.96

806.92

e6/l

0.39

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

11.70

8.06

3.6

4.7

—

(3018133) Calcium [Moles/volume] in Urine

4.27

7.93

3.6

2.2

2.43

2.41

mmol/l

0.01

(3037692) Legionella sp identified in Specimen by Organism specific culture

100

3.11

7.81

1.5

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2966

27787

1.21

7.81

4.6

3.8

1.45

1.24

mmol/l

32.90

2620

24622

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

3.17

7.79

1.3

1.4

19.00

24.58

0.44

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.39

7.79

1.1

1644.81

1411.04

miu/ml

0.53

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

127

2.85

7.78

1.3

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

3.54

7.68

1.6

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

181

2.50

7.56

3.7

3.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

152

2.65

7.53

1.4

1.8

—

(4281824) Cell count and differential, peritoneal fluid

269

2.21

7.49

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

403

1.98

7.48

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

125

2.81

7.41

1.3

1.9

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

3.27

7.37

1.1

5.40

6.60

u/ml

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

126

2.79

7.31

3.0

2.4

44240.00

40578.76

ug/l

0.54

126

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

10.86

7.29

3.8

4.6

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.30

7.21

2.3

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

3.12

7.12

3.3

2.7

25.48

29.13

umol/l

1.00

(3021387) Prolactin [Units/volume] in Serum or Plasma

110

636

1.75

7.05

2.1

1.5

392.44

287.38

mu/l

1.13

579

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

123

2.78

7.05

1.3

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

123

2.78

7.05

1.3

1.9

—

(3042517) Benzodiazepines panel - Urine

10.03

7.02

1.4

2.9

—

(3044007) Cell count panel - Peritoneal fluid

3.30

6.95

2.0

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3081

29096

1.20

6.90

5.0

4.2

4.20

4.56

mmol/l

65.53

2757

26211

(40768804) Tissue Pathology biopsy report

1378

12139

1.20

6.83

2.4

2.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

243

2.20

6.68

1.5

1.3

70.00

65.29

titre

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

133

2.64

6.63

1.7

1.4

5.33

6.23

u/l

0.65

113

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.57

6.58

9.3

7.7

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.74

6.35

2.1

2.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.04

6.33

2.0

1.5

7239.63

24181.87

e6/l

0.42

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

302

2.03

6.33

1.2

115.87

111.09

0.40

271

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

108

2.79

6.30

2.1

1.9

173.16

155.62

0.39

101

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.34

6.26

1.3

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

18.03

6.26

3.7

4.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

250

2.13

6.25

1.6

1.3

273.75

266.82

titre

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

186

2.32

6.23

1.3

1.5

15.52

14.62

umol/l

0.26

170

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

231

2.18

6.21

1.0

—

(3047189) Immunofixation for 24 hour Urine

132

2.59

6.19

1.5

1.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

219

2.20

6.15

1.5

1.4

26.27

25.19

u/l

0.06

184

(3026389) Candida sp identified in Specimen by Organism specific culture

391

1.88

6.06

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

170

2.37

6.04

1.1

257.31

275.95

mg/l

0.20

142

(3014051) Protein [Presence] in Urine by Test strip

126

792

1.61

5.96

4.0

2.6

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3144

29901

1.19

5.84

5.4

4.7

2.36

2.69

mmol/l

71.28

2814

26728

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3038

28814

1.18

5.80

4.9

4.2

1.35

1.45

mmol/l

32.87

2696

25752

(3006442) Creatine [Moles/volume] in Serum or Plasma

199

2.22

5.78

1.8

1.5

111.02

86.90

umol/l

0.65

199

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

537

4362

1.26

5.76

1.3

1.2

38.31

39.40

iu/ml

0.05

159

1337

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

321

1.94

5.72

1.2

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.18

5.69

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

5.18

5.69

1.8

2.1

17.13

16.40

umol/l

0.07

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.04

5.64

1.4

1.1

90.08

81.57

0.58

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

202

2.19

5.58

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

338

1.91

5.58

2.3

1.68

1.89

u/field

0.17

109

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.47

5.44

9.6

7.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

242

1776

1.38

5.36

1.8

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.10

5.33

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

241

1772

1.38

5.28

2.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

181

2.22

5.27

1.2

1.1

48.94

37.67

mg/l

0.46

139

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

201

2.15

5.24

1.0

253.19

340.17

ng/l

1.05

127

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

346

1.86

5.22

1.4

1.2

3.09

3.81

u/ml

0.22

129

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

5.92

5.21

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.65

5.20

1.9

1.4

138.68

127.14

ng/l

0.09

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.76

5.19

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.76

5.19

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

126

2.47

5.19

1.1

1.05

1.07

ratio

0.29

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.88

5.18

1.5

2.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

202

2.14

5.18

1.1

1.0

643.54

693.82

ng/l

0.28

122

(3021788) Differential panel - Synovial fluid

578

1.66

5.16

1.7

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

3.34

5.16

1.7

1.2

323.84

39.74

mu/l

0.89

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.80

5.13

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.80

5.13

1.1

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

152

2.31

5.09

1.6

1.5

2.29

4.72

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

146

2.34

5.07

3.1

2.9

41.96

38.41

0.69

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

328

1.87

5.07

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

592

0.40

5.05

1.8

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.70

4.98

1.1

1.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.81

4.97

1.2

1.3

111.50

112.78

0.09

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.89

4.94

4.6

4.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1399

12606

1.16

4.93

4.7

5.2

5.64

4.44

ug/l

0.21

1187

11185

(3034274) Bile acid [Moles/volume] in Serum --fasting

241

2.00

4.88

2.3

20.43

7.76

umol/l

0.60

174

(3022621) pH of Urine by Test strip

278

2118

1.33

4.87

4.4

3.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

277

1.92

4.81

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

202

2.09

4.79

1.0

28.78

47.00

ng/l

3.15

126

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

5.73

4.74

1.5

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

388

1.76

4.69

1.5

63.08

61.17

0.14

250

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.76

4.60

1.6

1.4

—

(21494434) Karyotype in Bone marrow

289

1.88

4.59

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.68

4.57

1.1

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

116

2.42

4.54

1.4

1.3

77.20

62.27

1.80

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

171

1219

1.42

4.53

4.1

3.4

65.75

84.56

u/ml

0.49

166

1174

(3035320) C reactive protein [Mass/volume] in Body fluid

221

2.00

4.49

3.6

2.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

129

2.33

4.49

1.9

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

894

0.54

4.47

1.8

1.7

—

(3045462) Protein/Creatinine [Ratio] in Urine

4.06

4.39

4.3

8.1

50.32

58.53

g/mol

0.12

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

837

0.53

4.39

3.0

1.7

5.55

4.20

mg/l

0.18

597

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.74

4.34

1.4

1.2

94.42

82.41

0.88

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.74

4.34

1.7

1.2

112.33

99.38

0.71

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

170

2.13

4.33

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.96

4.29

1.1

1.2

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.90

4.27

7.6

5.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

115

769

1.51

4.25

1.9

1.6

27863.56

13202.07

e6/l

1.08

560

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

493

4108

1.23

4.20

1.3

1.2

13.99

12.83

u/ml

0.12

182

1498

(3010370) Gastrin [Moles/volume] in Serum or Plasma

3.42

4.18

1.5

1.6

42.02

35.59

pmol/l

0.17

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.81

4.18

2.4

1.6

—

(3006245) CD3-CD19+ cells/100 cells in Blood

109

2.39

4.13

2.0

2.8

11.65

11.18

0.04

100

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

5.89

4.12

9.7

6.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

181

2.05

4.09

1.1

1.0

324.59

282.30

mg/l

1.69

154

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

331

1.76

4.05

1.4

1.2

4.83

3.72

u/ml

0.24

153

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.34

4.04

1.4

1.2

43.50

50.84

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

10.01

4.01

1.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

117

2.32

4.00

1.1

1.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

2.94

4.00

1.2

1.3

22.83

21.74

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

6.44

3.98

1.1

1.0

—

(3024263) Appearance of Synovial fluid

177

2.04

3.93

1.4

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

157

2.11

3.93

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.79

3.88

1.1

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

204

1542

1.34

3.83

1.2

197.16

129.30

iu/ml

0.32

542

(3016244) Insulin [Units/volume] in Serum or Plasma

139

2.17

3.82

2.8

3.3

24.44

26.14

mu/l

0.07

130

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.54

3.79

1.2

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.95

3.79

1.2

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

8.76

3.77

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

108

2.32

3.75

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.51

3.70

1.2

1.3

0.32

0.30

g/l

0.44

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

110

2.28

3.61

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.72

3.58

2.8

1.5

45.31

46.46

umol/l

0.05

(3013336) Amino acids [Identifier] in Serum or Plasma

7.79

3.55

2.4

2.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

323

1.71

3.52

1.5

1.3

136580.23

102571.18

e6/l

0.15

226

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.81

3.52

1.1

—

(3002256) Pathology report gross observation

480

4063

1.20

3.51

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

254

3187

0.78

3.48

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

726

0.56

3.46

1.5

—

(4146454) Self-monitoring of blood glucose

310

1.72

3.45

2.6

2.5

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

106

2.27

3.44

1.8

2.7

33.67

30.13

0.44

100

(3025549) Creatine [Moles/time] in 24 hour Urine

4.08

3.39

1.5

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

130

935

1.40

3.37

1.8

1.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

5.01

3.37

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.10

3.36

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.10

3.36

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

328

1.69

3.35

1.3

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.72

3.32

2.5

2.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

108

2.23

3.31

1.0

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.94

3.28

1.4

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

101

701

1.45

3.20

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

4.17

3.19

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.86

3.18

1.7

1.1

88.40

72.59

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

6.37

3.18

13.4

6.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

111

2.17

3.12

1.0

1.1

2742.00

273.32

ng/l

—

(4200892) Spirometry reversibility

261

2101

1.26

3.11

1.5

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.68

3.05

1.1

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.18

3.05

1.1

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.18

3.05

1.1

1.0

—

(3002619) Bacteria identified in Specimen by Culture

2.51

3.03

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

472

1.53

3.02

3.0

2.1

34.08

24.90

mg/l

0.54

108

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

10.01

2.98

1.0

2.40

1.40

u/field

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.47

2.95

2.4

1.3

93.60

133.07

nmol/l

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.83

2.91

1.4

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

228

1.76

2.90

1.1

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.67

2.86

1.3

1.6

—

(36660697) Celiac disease serology panel - Serum

254

2060

1.25

2.86

1.3

1.2

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

238

1.73

2.80

2.7

2.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

646

1.43

2.79

1.3

1.2

7.14

4.79

u/ml

0.19

105

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

547

1.47

2.78

1.3

1.2

—

0.60

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.08

2.76

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

639

1.43

2.76

1.3

1.2

3.52

2.81

u/ml

0.19

(3050794) Legionella sp Ab [Presence] in Serum

5.01

2.72

1.1

—

(40768443) Skin Pathology biopsy report

179

1406

1.28

2.65

1.3

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.80

2.64

1.3

1.2

50.33

116.89

u/l

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.80

2.64

2.0

2.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.15

2.64

1.1

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

228

1.72

2.62

1.7

1.8

6.79

4.13

mg/l

1.37

215

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.66

2.62

1.1

1.2

17.79

18.79

u/l

0.10

(3038026) Centromere Ab [Units/volume] in Serum

237

1.69

2.57

1.3

1.1

—

63.76

—

(3046861) Legionella sp Ag [Presence] in Urine

4.00

2.56

1.4

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

582

1.43

2.56

1.1

1.3

220.23

226.34

miu/ml

0.03

247

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.86

2.54

2.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

5.46

2.54

1.8

1.4

4.62

4.48

mmol/l

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.46

2.54

1.2

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.46

2.54

1.2

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.42

2.53

1.2

1.1

0.83

0.70

umol/24h

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.42

2.53

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

423

0.52

2.53

1.4

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.60

2.53

1.8

4.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.32

2.48

1.3

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

353

0.48

2.47

1.6

—

(3028433) Virus identified in Specimen by Culture

102

2.06

2.46

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.81

2.46

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.90

2.41

4.5

2.5

0.55

0.37

u/field

0.28

(3000492) Spirometry study

302

2543

1.20

2.40

1.5

—

(3017509) Phencyclidine [Presence] in Urine

4.12

2.36

1.9

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

229

1.67

2.32

1.2

1.1

—

86.86

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.95

2.28

1.5

1.4

—

(4212803) Bone marrow aspirate examination

2.95

2.28

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.46

2.27

1.3

1.1

0.31

2.76

mmol/l

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

186

1.73

2.24

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

186

1.73

2.24

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.86

2.20

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

100

2.00

2.20

1.8

1.6

4.64

4.11

umol/l

0.23

(3048879) Bone marrow aspiration report

100

2.00

2.20

1.2

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.34

2.18

1.3

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.34

2.18

1.0

1.3

—

(3044941) Cell count panel - Synovial fluid

485

1.43

2.15

1.7

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.69

2.15

1.1

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

320

0.50

2.13

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

624

1.37

2.08

1.5

20.83

25.33

iu/l

0.71

512

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.71

2.06

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.50

2.05

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.18

2.04

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.18

2.04

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.18

2.04

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.18

2.04

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

314

0.51

2.02

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

274

0.47

2.02

1.6

1.5

—

(3005033) Fetal Nuchal fold Thickness US

312

0.51

1.99

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

802

7347

1.11

1.99

1.8

1.6

1.52

1.29

mmol/l

8.65

652

6016

(40768795) Lymph node Pathology biopsy report

280

1.54

1.97

1.2

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

726

0.69

1.94

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.17

1.82

1.4

1.0

—

(3020491) Glucose [Moles/volume] in Blood

222

1.58

1.81

2.4

2.1

8.19

6.69

mmol/l

1.34

145

(3036670) Protein [Mass/volume] in Synovial fluid

108

1.86

1.81

1.3

1.2

37.77

41.10

g/l

0.60

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.06

1.80

1.3

1.2

0.94

1.75

mmol/l

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.34

1.77

1.0

1.1

38.75

43.32

mg/l

0.11

(3003338) MCHC [Mass/volume]

2599

25180

1.08

1.74

50.7

18.9

328.91

331.93

g/l

42.62

2551

24840

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.92

1.72

2.0

4.1

—

(4034850) Laboratory test

128

1026

1.25

1.72

21.2

10.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

290

1.49

1.71

1.4

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

187

1.61

1.68

4.5

17.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

126

1.75

1.67

1.0

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.50

1.66

1.7

1.5

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.80

1.65

1.0

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

462

1.37

1.62

1.3

1.2

48.91

36.76

u/ml

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.57

1.61

1.0

1.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

143

1.68

1.60

2.8

1.5

0.83

0.92

g/l

0.54

143

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

1.59

1.0

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.00

1.58

1.3

1.2

3875.50

3985.18

ng/l

—

(1002224) Polysomnography panel

807

0.74

1.54

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.34

1.52

1.2

1.3

227.20

274.93

umol/24h

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

383

0.62

1.52

1.3

1.4

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

2.59

1.51

1.0

—

30.13

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.59

1.51

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

162

1930

0.83

1.51

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

382

0.63

1.50

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

381

0.63

1.49

1.3

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

131

1.68

1.49

1.4

1.3

6.25

6.07

mmol/l

0.20

126

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.95

1.48

1.4

1.5

14.89

8.53

ug/l

1.72

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.44

1.47

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

235

1.49

1.46

1.4

1.5

0.23

0.29

nmol/l

0.53

191

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.50

1.45

1.9

4.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.73

1.43

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.04

1.43

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.31

1.43

6.7

8.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

172

1.57

1.42

1.2

1.4

3.52

2.43

u/ml

—

100

(3006270) Folate [Moles/volume] in Blood

295

1.43

1.41

1.4

1.2

333.33

332.94

nmol/l

0.00

240

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

324

0.62

1.37

2.0

1.7

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.61

1.36

1.0

1.4

—

327.32

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.94

1.36

1.4

2.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

101

814

1.25

1.35

2.3

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

594

0.72

1.34

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

382

0.65

1.33

1.3

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.74

1.30

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

114

1.67

1.28

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

1.79

1.27

1.9

2.7

131.00

258.78

e6/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.22

1.24

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

203

0.54

1.24

1.3

1.4

91.25

179.46

pmol/l

1.85

203

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.86

1.23

2.5

4.8

5.75

7.71

mg/l

—

(3019174) dRVVT (LA screen)

2.63

1.21

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.63

1.21

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

124

1.62

1.20

1.1

1.0

1.10

1.14

u/l

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

172

1.51

1.20

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

172

1.51

1.20

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

172

1.51

1.20

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

238

0.59

1.19

1.1

9.03

5.75

u/ml

—

100

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

173

1.51

1.17

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

173

1.51

1.17

1.1

—

(3034426) Prothrombin time (PT)

1.77

1.16

1.5

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

248

0.60

1.15

1.1

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.50

1.15

1.0

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.50

1.15

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

174

1.50

1.15

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

734

1.23

1.13

4.2

3.6

28.10

30.40

mg/l

0.33

470

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.75

1.12

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.34

1.12

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

270

0.63

1.11

1.1

11.99

4.12

u/ml

—

133

(3036071) Salmonella sp Ab [Titer] in Serum

1.78

1.10

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

680

7253

0.93

1.09

2.9

3.2

0.89

0.82

ug/l

0.43

482

5077

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.38

1.09

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

204

1794

1.14

1.08

2.3

2.4

51.80

23.75

au/ml

—

113

(40768800) Prostate Pathology biopsy report

827

0.79

1.07

1.1

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.93

1.06

1.3

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

179

0.56

1.04

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

251

2250

1.12

1.01

2.4

2.1

10.72

12.67

nmol/l

2.95

209

1999

(3015183) Erythrocyte sedimentation rate

106

0.47

1.01

1.0

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

850

0.81

0.99

1.8

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

140

1.50

0.97

1.6

2.9

192.29

213.66

u/l

0.65

140

(3009871) Measles virus Ab [Titer] in Serum

1.74

0.96

1.4

1.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

505

1.25

0.96

1.9

1.8

178.48

214.58

pmol/l

1.66

478

(3050129) First trimester maternal screen panel - Serum or Plasma

467

0.75

0.94

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.89

0.94

1.0

—

(3006462) Nitrate [Presence] in Urine

168

1.43

0.89

5.4

3.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

183

1624

1.13

0.89

1.2

1.3

59.87

65.71

au/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

120

1.50

0.85

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

1.67

0.85

1.0

—

(40765096) Chromosome analysis panel by Banding

104

1.54

0.84

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

381

1.26

0.82

1.3

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.55

0.81

2.5

2.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

224

0.67

0.80

1.3

1.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.78

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.77

0.76

2.0

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.77

0.76

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.77

0.76

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.77

0.76

15.3

3.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.77

0.76

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

395

1.24

0.75

2.0

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

197

1783

1.11

0.73

2.1

2.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

326

1.26

0.71

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

326

1.26

0.71

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

147

1312

1.12

0.70

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.85

0.68

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1045

0.87

0.66

1.8

1.9

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.79

0.66

1.6

1.1

1.77

2.00

umol/24h

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.79

0.66

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.60

0.0

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

13.00

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

333

0.78

0.59

1.1

3.96

1.66

u/ml

0.64

186

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

640

1.16

0.58

1.2

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

263

2826

0.93

0.58

1.5

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

420

3971

1.06

0.58

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

521

1.17

0.57

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.51

0.56

2.5

2.3

5.78

7.77

mmol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.50

0.54

1.1

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.43

0.52

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

358

0.81

0.50

1.1

9.96

5.80

u/ml

0.54

202

(3008401) Mugwort IgE Ab [Units/volume] in Serum

347

0.81

0.50

1.1

2.51

1.37

u/ml

0.33

180

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

172

1.28

0.48

5.3

4.5

79.20

41.25

u/ml

—

(3020650) Glucose [Presence] in Urine

1.41

0.46

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.43

0.46

1.0

1.1

—

(3001729) Color of Synovial fluid

1.56

0.42

1.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.36

0.41

1.4

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.40

0.0

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

211

1986

1.07

0.38

2.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.39

0.38

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

236

0.80

0.38

1.8

1.9

1.32

1.95

ug/l

1.57

195

(3025018) Bordetella pertussis Ab [Titer] in Serum

143

1.26

0.36

1.3

1.2

—

(3008898) HLA-B27 [Presence]

714

0.89

0.36

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

145

0.76

0.34

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

103

1.26

0.28

8.0

6.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

390

4024

0.97

0.26

4.9

4.3

33.44

33.07

0.26

280

2602

(1617658) Protocol used for examination of sentinel lymph nodes

210

0.86

0.22

1.1

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

652

1.07

0.21

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1030

10150

1.02

0.21

4.0

4.5

21.39

22.00

0.59

505

5393

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.21

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

406

0.91

0.19

1.3

1.2

1.14

2.59

u/ml

1.08

230

(40765089) Chromosome analysis panel - Blood by G-banded

1.15

0.17

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.76

0.17

4.0

5.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.73

0.17

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

120

0.83

0.16

1.0

1.3

1.49

1.54

g/l

—

120

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.11

0.15

1.6

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

336

0.92

0.13

1.3

1.2

—

(44813793) Dust mix specific IgE antibody measurement

169

0.89

0.12

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

344

0.93

0.12

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

188

1833

1.03

0.12

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

107

1.12

0.08

4.3

1.8

11.11

122.21

ug/l

0.81

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.12

0.07

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

122

0.90

0.07

1.2

1.1

—

(40768793) Breast Pathology biopsy report

574

1.03

0.05

1.4

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

125

1.04

0.00

1.0

1.3

—

(3025130) Human papilloma virus identified in Specimen

215

0.98

0.00

1.9

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

140

1.00

0.00

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

899

8993

1.00

0.00

3.6

2.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

121

0.99

0.00

1.4

1.1

0.23

0.95

u/ml

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.02

-0.00

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

6.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

-0.00

0.0

1.7

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

4.11

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.95

-0.00

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.89

-0.00

1.0

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.99

-0.00

4.4

1.7

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.00

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_VOLUME and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_VOLUME	2.989 [2.56, 3.49]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.148

During the follow-up period (1.1.1998 — 31.12.2019), 10523 out of 18446 females with E4_VOLUME died.

Males

Parameter	HR [95% CI]	p-value
E4_VOLUME	3.723 [3.05, 4.54]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 7499 out of 14569 males with E4_VOLUME died.

Mortality risk

Mortality risk for people of age

years, who have E4_VOLUME.

N-year risk	Females	Males
1	0.25%	0.576%
5	1.584%	4.141%
10	4.033%	9.338%
15	7.718%	16.64%
20	13.341%	27.523%

Relationships between endpoints

↥

Index endpoint: E4_VOLUME – Volume depletion

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Volume depletion

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints